The period of the MENSTRUAL CYCLE representing follicular growth, increase in ovarian estrogen (ESTROGENS) production, and epithelial proliferation of the ENDOMETRIUM. Follicular phase begins with the onset of MENSTRUATION and ends with OVULATION.
The period in the MENSTRUAL CYCLE that follows OVULATION, characterized by the development of CORPUS LUTEUM, increase in PROGESTERONE production by the OVARY and secretion by the glandular epithelium of the ENDOMETRIUM. The luteal phase begins with ovulation and ends with the onset of MENSTRUATION.
The period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase.
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.
A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity.
A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity.
An OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment (FOLLICULAR FLUID). The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS.
The discharge of an OVUM from a rupturing follicle in the OVARY.
An inactive metabolite of PROGESTERONE by reduction at C5, C3, and C20 position. Pregnanediol has two hydroxyl groups, at 3-alpha and 20-alpha. It is detectable in URINE after OVULATION and is found in great quantities in the pregnancy urine.
The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE.
The period in the ESTROUS CYCLE associated with maximum sexual receptivity and fertility in non-primate female mammals.
A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
Glycoproteins that inhibit pituitary FOLLICLE STIMULATING HORMONE secretion. Inhibins are secreted by the Sertoli cells of the testes, the granulosa cells of the ovarian follicles, the placenta, and other tissues. Inhibins and ACTIVINS are modulators of FOLLICLE STIMULATING HORMONE secretions; both groups belong to the TGF-beta superfamily, as the TRANSFORMING GROWTH FACTOR BETA. Inhibins consist of a disulfide-linked heterodimer with a unique alpha linked to either a beta A or a beta B subunit to form inhibin A or inhibin B, respectively
A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND.
Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum.
The period of cyclic physiological and behavior changes in non-primate female mammals that exhibit ESTRUS. The estrous cycle generally consists of 4 or 5 distinct periods corresponding to the endocrine status (PROESTRUS; ESTRUS; METESTRUS; DIESTRUS; and ANESTRUS).
The fluid surrounding the OVUM and GRANULOSA CELLS in the Graafian follicle (OVARIAN FOLLICLE). The follicular fluid contains sex steroids, glycoprotein hormones, plasma proteins, mucopolysaccharides, and enzymes.
Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS.
A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.
Steroid hormones produced by the GONADS. They stimulate reproductive organs, germ cell maturation, and the secondary sex characteristics in the males and the females. The major sex steroid hormones include ESTRADIOL; PROGESTERONE; and TESTOSTERONE.
Hormones that stimulate gonadal functions such as GAMETOGENESIS and sex steroid hormone production in the OVARY and the TESTIS. Major gonadotropins are glycoproteins produced primarily by the adenohypophysis (GONADOTROPINS, PITUITARY) and the placenta (CHORIONIC GONADOTROPIN). In some species, pituitary PROLACTIN and PLACENTAL LACTOGEN exert some luteotropic activities.
Hormones secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR) that stimulate gonadal functions in both males and females. They include FOLLICLE STIMULATING HORMONE that stimulates germ cell maturation (OOGENESIS; SPERMATOGENESIS), and LUTEINIZING HORMONE that stimulates the production of sex steroids (ESTROGENS; PROGESTERONE; ANDROGENS).
A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL.
A glycoprotein that causes regression of MULLERIAN DUCTS. It is produced by SERTOLI CELLS of the TESTES. In the absence of this hormone, the Mullerian ducts develop into structures of the female reproductive tract. In males, defects of this hormone result in persistent Mullerian duct, a form of MALE PSEUDOHERMAPHRODITISM.
Suspension or cessation of OVULATION in animals or humans with follicle-containing ovaries (OVARIAN FOLLICLE). Depending on the etiology, OVULATION may be induced with appropriate therapy.
Methods used for assessment of ovarian function.
Variations of menstruation which may be indicative of disease.
An assisted reproductive technique that includes the direct handling and manipulation of oocytes and sperm to achieve fertilization in vitro.
Predicting the time of OVULATION can be achieved by measuring the preovulatory elevation of ESTRADIOL; LUTEINIZING HORMONE or other hormones in BLOOD or URINE. Accuracy of ovulation prediction depends on the completeness of the hormone profiles, and the ability to determine the preovulatory LH peak.
An aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE directly, or from TESTOSTERONE via ESTRADIOL. In humans, it is produced primarily by the cyclic ovaries, PLACENTA, and the ADIPOSE TISSUE of men and postmenopausal women.
Diminished or absent ability of a female to achieve conception.
The period before MENOPAUSE. In premenopausal women, the climacteric transition from full sexual maturity to cessation of ovarian cycle takes place between the age of late thirty and early fifty.
The yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE.
A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN).
A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue. Note that ENCLOMIPHENE and ZUCLOMIPHENE are the (E) and (Z) isomers of Clomiphene respectively.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
Method to determine the occurrence of OVULATION by direct or indirect means. Indirect methods examine the effects of PROGESTERONE on cervical mucus (CERVIX MUCUS), or basal body temperature. Direct ovulation detection, generally used in fertility treatment, involves analyses of circulating hormones in blood and ULTRASONOGRAPHY.
The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.
A synthetic prostaglandin F2alpha analog. The compound has luteolytic effects and is used for the synchronization of estrus in cattle.
Occurrence or induction of release of more ova than are normally released at the same time in a given species. The term applies to both animals and humans.
Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.
The degeneration and resorption of an OVARIAN FOLLICLE before it reaches maturity and ruptures.
Postcoital contraceptives which owe their effectiveness to synthetic preparations.
The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.
The surgical removal of one or both ovaries.
Degradation of CORPUS LUTEUM. In the absence of pregnancy and diminishing trophic hormones, the corpus luteum undergoes luteolysis which is characterized by the involution and cessation of its endocrine function.
A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM.
Compounds which increase the capacity to conceive in females.
Absence of menstruation.
Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation.
Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.
A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.
An anabolic steroid used mainly as an anabolic agent in veterinary practice.
Steroidal compounds related to PROGESTERONE, the major mammalian progestational hormone. Progesterone congeners include important progesterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with progestational activities.
Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.
The amount of a substance secreted by cells or by a specific organ or organism over a given period of time; usually applies to those substances which are formed by glandular tissues and are released by them into biological fluids, e.g., secretory rate of corticosteroids by the adrenal cortex, secretory rate of gastric acid by the gastric mucosa.
Extracts of urine from menopausal women that contain high concentrations of pituitary gonadotropins, FOLLICLE STIMULATING HORMONE and LUTEINIZING HORMONE. Menotropins are used to treat infertility. The FSH:LH ratio and degree of purity vary in different preparations.
Supporting cells for the developing female gamete in the OVARY. They are derived from the coelomic epithelial cells of the gonadal ridge. Granulosa cells form a single layer around the OOCYTE in the primordial ovarian follicle and advance to form a multilayered cumulus oophorus surrounding the OVUM in the Graafian follicle. The major functions of granulosa cells include the production of steroids and LH receptors (RECEPTORS, LH).
The beta subunit of follicle stimulating hormone. It is a 15-kDa glycopolypeptide. Full biological activity of FSH requires the non-covalently bound heterodimers of an alpha and a beta subunit. Mutation of the FSHB gene causes delayed puberty, or infertility.
A potent synthetic analog of GONADOTROPIN-RELEASING HORMONE with D-serine substitution at residue 6, glycine10 deletion, and other modifications.
A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.
A state of sexual inactivity in female animals exhibiting no ESTROUS CYCLE. Causes of anestrus include pregnancy, presence of offspring, season, stress, and pathology.
A slightly alkaline secretion of the endocervical glands. The consistency and amount are dependent on the physiological hormone changes in the menstrual cycle. It contains the glycoprotein mucin, amino acids, sugar, enzymes, and electrolytes, with a water content up to 90%. The mucus is a useful protection against the ascent of bacteria and sperm into the uterus. (From Dictionary of Obstetrics and Gynecology, 1988)
Hormones produced in the testis.
A major gonadotropin secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and the LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. The alpha subunit is common in the three human pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity.
Occurrence or induction of ESTRUS in all of the females in a group at the same time, applies only to non-primate mammals with ESTROUS CYCLE.
The flattened stroma cells forming a sheath or theca outside the basal lamina lining the mature OVARIAN FOLLICLE. Thecal interstitial or stromal cells are steroidogenic, and produce primarily ANDROGENS which serve as precusors of ESTROGENS in the GRANULOSA CELLS.
General term for CYSTS and cystic diseases of the OVARY.
A genus of the subfamily CALLITRICHINAE occurring in forests of Brazil and Bolivia and containing seventeen species.
An enzyme that catalyzes the desaturation (aromatization) of the ring A of C19 androgens and converts them to C18 estrogens. In this process, the 19-methyl is removed. This enzyme is membrane-bound, located in the endoplasmic reticulum of estrogen-producing cells of ovaries, placenta, testes, adipose, and brain tissues. Aromatase is encoded by the CYP19 gene, and functions in complex with NADPH-FERRIHEMOPROTEIN REDUCTASE in the cytochrome P-450 system.
The ratio of the number of conceptions (CONCEPTION) including LIVE BIRTH; STILLBIRTH; and fetal losses, to the mean number of females of reproductive age in a population during a set time period.
Gonadotropins secreted by the pituitary or the placenta in horses. This term generally refers to the gonadotropins found in the pregnant mare serum, a rich source of equine CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE; and FOLLICLE STIMULATING HORMONE. Unlike that in humans, the equine LUTEINIZING HORMONE, BETA SUBUNIT is identical to the equine choronic gonadotropin, beta. Equine gonadotropins prepared from pregnant mare serum are used in reproductive studies.
A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE with D-tryptophan substitution at residue 6.
A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions.
A glycoprotein migrating as a beta-globulin. Its molecular weight, 52,000 or 95,000-115,000, indicates that it exists as a dimer. The protein binds testosterone, dihydrotestosterone, and estradiol in the plasma. Sex hormone-binding protein has the same amino acid sequence as ANDROGEN-BINDING PROTEIN. They differ by their sites of synthesis and post-translational oligosaccharide modifications.
A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate.
Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.
The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.
The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed)
Large mammals in the family Elephantidae, with columnar limbs, bulky bodies, and elongated snouts. They are the only surviving members of the PROBOSCIDEA MAMMALS.
The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality.
Metabolites or derivatives of PROGESTERONE with hydroxyl group substitution at various sites.
Oral contraceptives which owe their effectiveness to hormonal preparations.
A condition observed in WOMEN and CHILDREN when there is excess coarse body hair of an adult male distribution pattern, such as facial and chest areas. It is the result of elevated ANDROGENS from the OVARIES, the ADRENAL GLANDS, or exogenous sources. The concept does not include HYPERTRICHOSIS, which is an androgen-independent excessive hair growth.
Elements of limited time intervals, contributing to particular results or situations.
Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.
The transfer of mammalian embryos from an in vivo or in vitro environment to a suitable host to improve pregnancy or gestational outcome in human or animal. In human fertility treatment programs, preimplantation embryos ranging from the 4-cell stage to the blastocyst stage are transferred to the uterine cavity between 3-5 days after FERTILIZATION IN VITRO.
The number of males per 100 females.
Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA).
The circulating form of a major C19 steroid produced primarily by the ADRENAL CORTEX. DHEA sulfate serves as a precursor for TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE.
A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.
A mechanism of communication within a system in that the input signal generates an output response which returns to influence the continued activity or productivity of that system.
The anterior glandular lobe of the pituitary gland, also known as the adenohypophysis. It secretes the ADENOHYPOPHYSEAL HORMONES that regulate vital functions such as GROWTH; METABOLISM; and REPRODUCTION.
Clinical and laboratory techniques used to enhance fertility in humans and animals.
A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed)
Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.
A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans.
The tendency of a phenomenon to recur at regular intervals; in biological systems, the recurrence of certain activities (including hormonal, cellular, neural) may be annual, seasonal, monthly, daily, or more frequently (ultradian).
The process of bearing developing young (EMBRYOS or FETUSES) in utero in non-human mammals, beginning from FERTILIZATION to BIRTH.

Uterine peristalsis during the follicular phase of the menstrual cycle: effects of oestrogen, antioestrogen and oxytocin. (1/787)

Uterine peristalsis, directing sustained and rapid sperm transport from the external cervical os or the cervical crypts to the isthmic part of the tube ipsilateral to the dominant follicle, changes in direction and frequency during the menstrual cycle, with lowest activity during menstruation and highest activity at mid cycle. It was therefore suggested that uterine peristalsis is under the control of the dominant follicle with the additional involvement of oxytocin. To test this hypothesis, vaginal sonography of uterine peristalsis was performed in the early, mid and late proliferative phases, respectively, of cycles of women treated with oestradiol valerate and with human menopausal gonadotrophin following pituitary downregulation, with clomiphene citrate and with intravenous oxytocin, respectively. Administration of oestradiol valerate resulted in oestradiol serum concentrations comparable with the normal cycle with a simulation of the normal frequency of peristaltic contractions. Elevated oestradiol concentrations and bolus injections of oxytocin resulted in a significant increase in the frequency of peristaltic contractions in the early and mid follicular phases, respectively. Chlomiphene tended, though insignificantly so, to suppress the frequency of peristaltic waves in the presence of elevated oestradiol concentrations. In the late follicular phase of the cycle extremely elevated oestradiol concentrations as well as the injection of oxytocin resulted only in an insignificant further increase of peristaltic frequency. In the normal cycles, as well as during extremely elevated oestradiol concentrations and following oxytocin administration, the peristaltic contractions were always confined to the subendometrial layer of the muscular wall. The results and the review of literature indicate that uterine peristalsis during the follicular phase of the menstrual cycle is controlled by oestradiol released from the dominant follicle with the probable involvement of oxytocin, which is presumably stimulated together with its receptor within the endometrial-subendometrial unit and therefore acting in an autocrine/paracrine fashion. Since unphysiological stimulation with oestradiol and oxytocin did not significantly increase the frequency of uterine peristalsis in the late follicular phase of the cycle it is assumed that normal preovulatory frequency of uterine peristalsis is at a level which cannot be significantly surpassed due to phenomena of refractoriness of the system.  (+info)

Incompetence of preovulatory mouse oocytes to undergo cortical granule exocytosis following induced calcium oscillations. (2/787)

Immature oocytes of many species are incompetent to undergo cortical granule (CG) exocytosis upon fertilization. In mouse eggs, CG exocytosis is dependent primarily on an inositol 1,4,5-trisphosphate (IP3)-mediated elevation of intracellular calcium ([Ca2+]i). While deficiencies upstream of [Ca2+]i release are known, this study examined whether downstream deficiencies also contribute to the incompetence of preovulatory mouse oocytes to release CGs. The experimental strategy was to bypass upstream deficiencies by inducing normal, fertilization-like [Ca2+]i oscillations in fully grown, germinal vesicle (GV) stage oocytes and determine if the extent of CG exocytosis was restored to levels observed in mature, metaphase II (MII)-stage eggs. Because IP3 does not stimulate a normal Ca2+ response in GV-stage oocytes, three alternate methods were used to induce oscillations: thimerosal treatment, electroporation, and sperm factor injection. Long-lasting oscillations from thimerosal treatment resulted in 64 and 10% mean CG release at the MII and GV stages, respectively (P < 0.001). Three electrical pulses induced mean [Ca2+]i elevations of approximately 730 and 650 nM in MII- and GV-stage oocytes, respectively, and 31% CG release in MII-stage eggs and 9% in GV-stage oocytes (P < 0.001). Sperm factor microinjection resulted in 86% CG release in MII-stage eggs, while similarly treated GV-stage oocytes exhibited < 1% CG release (P < 0.001). Taken together, these results demonstrate a deficiency downstream of [Ca2+]i release which is developmentally regulated in the 12 h prior to ovulation.  (+info)

Physiological variability of fluid-regulation hormones in young women. (3/787)

We tested the physiological reliability of plasma renin activity (PRA) and plasma concentrations of arginine vasopressin (P[AVP]), aldosterone (P[ALD]), and atrial natriuretic peptide (P[ANP]) in the early follicular phase and midluteal phases over the course of two menstrual cycles (n = 9 women, ages 25 +/- 1 yr). The reliability (Cronbach's alpha >/=0.80) of these hormones within a given phase of the cycle was tested 1) at rest, 2) after 2.5 h of dehydrating exercise, and 3) during a rehydration period. The mean hormone concentrations were similar within both the early follicular and midluteal phase tests; and the mean concentrations of P[ALD] and PRA for the three test conditions were significantly greater during the midluteal compared with the early follicular phase. Although Cronbach's alpha for resting and recovery P[ANP] were high (0.80 and 0.87, respectively), the resting and rehydration values for P[AVP], P[ALD], and PRA were variable between trials for the follicular (alpha from 0.49 to 0.55) and the luteal phase (alpha from 0.25 to 0. 66). Physiological reliability was better after dehydration for P[AVP] and PRA but remained low for P[ALD]. Although resting and recovery P[AVP], P[ALD], and PRA were not consistent within a given menstrual phase, the differences in the concentrations of these hormones between the different menstrual phases far exceeded the variability within the phases, indicating that the low within-phase reliability does not prevent the detection of menstrual phase-related differences in these hormonal variables.  (+info)

Luteinization and proteolysis in ovarian follicles of Meishan and Large White gilts during the preovulatory period. (4/787)

This experiment was conducted to determine why follicles luteinize faster in the Meishan breed than in the Large White breed of pig. Follicles were recovered during the late follicular phase from ovaries of both breeds before and after administration of hCG given to mimic the LH surge. First, the patterns of cholesterol transporters (high and low density lipoproteins: HDL and LDL) were compared. Cholesterol transporters detected in follicular fluid consisted of HDL only. Similar amounts of Apolipoprotein A-I were found in all samples. There was no obvious breed effect on minor lipoproteins found in the HDL-rich fraction, and this pattern was altered similarly by hCG in the two breeds. The LDL-rich samples of serum from both breeds contained similar amounts of protein. Second, three steroidogenic enzymes, adrenodoxin, 17 alpha-hydroxylase-lyase (P450(17) alpha) and 3 beta-hydroxysteroid-dehydrogenase (3 beta-HSD) were detected by immunohistochemistry and quantified by image analysis on sections of the two largest follicles. Before hCG treatment, theca interna cells demonstrated immunoreactivities for adrenodoxin (strong), P450(17) alpha and 3 beta-HSD (very strong), whereas granulosa cells displayed immunoreactivities for adrenodoxin only. After hCG treatment, the localization of the enzymes was unchanged but the staining intensity of adrenodoxin on granulosa cells and 3 beta-HSD on theca cells increased (P < 0.01 and P < 0.05, respectively). Breed effects were detected for the amounts of adrenodoxin in theca cells (Meishan > Large White; P < 0.05) and of 17 alpha-hydroxylase (Large White > Meishan, P < 0.01). Breed x treatment interactions were never detected. Finally, gelatinases, plasminogen activator, plasminogen activator inhibitor, tissue inhibitors of metalloproteases (TIMP-1 and TIMP-2) were visualized by direct or reverse zymography or western blotting. Whatever the stage relative to LH administration, follicular fluid from Large White gilts contained more TIMP-1, and TIMP-2 (P < 0.02 and P < 0.01, respectively). No breed effect was detected for the amounts of gelatinases and plasminogen activator inhibitor 1. However, for these parameters, a significant breed x time interaction was obvious, as the Meishan follicles had a greater response to hCG (P < 0.01). Since proteolysis plays a key role in the bioavailability of growth factors such as insulin-like growth factor 1, fibroblast growth factor and transforming growth factor beta, which have the ability to alter gonadotrophin-induced progesterone production in pigs, the differences observed in its control in the present study may explain, at least in part, the different patterns of luteinization observed in Meishan and Large White follicles.  (+info)

Human metabolism of mammalian lignan precursors in raw and processed flaxseed. (5/787)

BACKGROUND: The mammalian lignans enterolactone and enterodiol are produced in the colon by the action of bacteria on the plant precursor secoisolariciresinol diglycoside, which is found in high concentrations in flaxseed. OBJECTIVE: Two experiments were conducted to determine 1) whether there is a dose response in urinary lignan excretion with increasing flaxseed intake, 2) whether flaxseed processing affects lignan excretion, 3) peak plasma lignan concentrations, and 4) plasma lignan concentrations after chronic supplementation. DESIGN: Nine healthy young women supplemented their diets with 5, 15, or 25 g raw or 25 g processed (muffin or bread) flaxseed for 7 d during the follicular phase of their menstrual cycles. Twenty-four-hour urine samples were collected at baseline and on the final day of supplementation. As an adjunct to the 25-g-flaxseed arm, subjects consumed the supplement for an additional day and blood and urine samples were collected at specific intervals. All blood and urine samples were analyzed for enterolactone and enterodiol by gas chromatography-mass spectroscopy. RESULTS: A dose-dependent urinary lignan response to raw flaxseed was observed (r = 0.72, P < 0.001). The processing of flaxseed as a muffin or bread did not affect the quantity of lignan excretion. Plasma lignan concentrations were greater (P < or = 0.05) than baseline by 9 h after flaxseed ingestion (29.35+/-3.69 and 51.75+/-7.49 nmol/L, respectively). The total plasma area under the curve was higher on the eighth than on the first day (1840.15+/-343.02 and 1027.15+/-95.71 nmol x h/L, respectively). CONCLUSION: Mammalian lignan production from flaxseed precursors is dependent on time and dose but not on processing.  (+info)

A quantitative study of changes in the human corpus luteum microvasculature during the menstrual cycle. (6/787)

Endothelial cells are the most abundant cell type in the corpus luteum (CL), and changes in blood vessels have been proposed to play a pivotal role in CL regression. We have studied quantitatively the changes in the human granulosa-luteal microvasculature in CL of various ages: young (Days 17-19 of the cycle), mature (Days 20-24), old (Days 25-27), early regressing (follicular phase of the following cycle), and late regressing (luteal phase of the following cycle). Blood vessels were identified by immunohistochemical staining for the endothelial cell marker CD34. Because of the anisotropy of blood vessels, both vertical and transverse sections of the granulosa-lutein layer (GLL) were used to estimate relative (volume, surface, and length densities) and absolute (mean cross-sectional area) vascular variables. Full luteinization from young to mature CL was accompanied by a 61% increase in the mean cross-sectional area of vascular profiles and a 52% increase in the mean volume of granulosa-lutein cells, as an estimator of changes in the volume of the GLL. In old and early regressing CL, there was a progressive increase in relative structural vascular variables, due to the shrinkage of the GLL, whereas the mean cross-sectional area of capillaries showed a 53% decrease from mature to old CL. Finally, in late regressing CL, there was a decrease in most relative structural variables, in spite of the increasingly shrunken GLL. The decrease in the capillary diameter found at the late luteal phase most likely leads to a decreased blood flow, and early changes in blood vessels could initiate and/or accelerate CL regression.  (+info)

Induction of macrophage migration inhibitory factor in human ovary by human chorionic gonadotrophin. (7/787)

The role of macrophage migration inhibitory factor (MIF) in human ovarian function remains obscure. The aim of this study was to investigate how MIF was related to ovulation by quantitative analysis of serum, follicular fluid and culture medium of granulosa cells obtained from in-vitro fertilization (IVF) and embryo transfer patients. Serum MIF concentrations in ovarian stimulation cycles for IVF-embryo transfer were higher at day 1 (median 92.6 ng/ml), which took place 35 h after human chorionic gonadotrophin (HCG) administration and just before the retrieval of oocytes, than those before day -6 (12.1 ng/ml), at day -5 to about day 0 (17.5 ng/ml) or at day 2 to about day 14 (8.2 ng/ml). MIF concentrations in the follicular fluid (113.4 ng/ml) obtained in ovarian stimulation cycles for IVF-embryo transfer were significantly higher than in serum (72.0 ng/ml) collected at the same time. MIF concentrations in the follicular fluid in natural cycles were higher in the ovulatory phase (51.6 ng/ml) than in the late follicular phase (13.8 ng/ml). MIF concentrations in the culture media of granulosa cells increased from 3.2 ng/ml to 7.2 ng/ml with HCG stimulation, and decreased from 2.4 ng/ml to 1.2 ng/ml when stimulation was withheld. These results indicate that HCG can induce the elevation of serum and follicular fluid MIF concentrations through the stimulation of ovarian cells, and that MIF is probably involved in the mechanism of ovulation.  (+info)

Fluctuations in CA 125 and CA 15-3 serum concentrations during spontaneous ovulatory cycles. (8/787)

The aim of this study was to investigate cycle dependent changes of serum CA 125 and CA 15-3 concentrations during spontaneous ovulatory cycles. Twenty apparently healthy women with spontaneous menstrual cycles attending our infertility clinic were included. Of these women, 18 had occluded tubes as a result of sterilization. Ovulation was confirmed by luteinizing hormone test and ultrasonography and, to exclude endometriosis, a laparoscopy was performed. Serum samples for CA 125, CA 15-3, 17 beta-oestradiol and progesterone determinations were taken every second day starting on the 2nd day of the cycle until the 7th day of the next cycle. After correction for inter-individual variation in serum concentrations, highest CA 125 concentrations were found during the menstruation. During the follicular and peri-ovulatory phase CA 125 serum concentrations were lowest. For CA 15-3, serum concentrations were not statistically different throughout the cycle. CA 125 and oestradiol concentrations were negatively correlated, CA 15-3 and oestradiol concentrations were positively correlated. Absolute serum concentrations of both CA 125 and CA 15-3 vary among females. Within the female, fluctuations of CA 125 are phase related. In the population studied most of the patients had tubal obstruction and high CA 125 serum concentrations during menstruation, which revokes the theory that the menstrual rise of CA 125 is due only to retrograde menstruation.  (+info)

The follicular phase is a term used in reproductive endocrinology, which refers to the first part of the menstrual cycle. This phase begins on the first day of menstruation and lasts until ovulation. During this phase, several follicles in the ovaries begin to mature under the influence of follicle-stimulating hormone (FSH) released by the pituitary gland.

Typically, one follicle becomes dominant and continues to mature, while the others regress. The dominant follicle produces increasing amounts of estrogen, which causes the lining of the uterus to thicken in preparation for a possible pregnancy. The follicular phase can vary in length, but on average it lasts about 14 days.

It's important to note that the length and characteristics of the follicular phase can provide valuable information in diagnosing various reproductive disorders, such as polycystic ovary syndrome (PCOS) or thyroid dysfunction.

The luteal phase is the second half of the menstrual cycle, starting from ovulation (release of an egg from the ovaries) and lasting until the start of the next menstruation. This phase typically lasts around 12-14 days in a regular 28-day menstrual cycle. During this phase, the remains of the dominant follicle that released the egg transform into the corpus luteum, which produces progesterone and some estrogen to support the implantation of a fertilized egg and maintain the early stages of pregnancy. If pregnancy does not occur, the corpus luteum degenerates, leading to a drop in hormone levels and the start of a new menstrual cycle.

The menstrual cycle is a series of natural changes that occur in the female reproductive system over an approximate 28-day interval, marking the body's preparation for potential pregnancy. It involves the interplay of hormones that regulate the growth and disintegration of the uterine lining (endometrium) and the release of an egg (ovulation) from the ovaries.

The menstrual cycle can be divided into three main phases:

1. Menstrual phase: The cycle begins with the onset of menstruation, where the thickened uterine lining is shed through the vagina, lasting typically for 3-7 days. This shedding occurs due to a decrease in estrogen and progesterone levels, which are hormones essential for maintaining the endometrium during the previous cycle.

2. Follicular phase: After menstruation, the follicular phase commences with the pituitary gland releasing follicle-stimulating hormone (FSH). FSH stimulates the growth of several ovarian follicles, each containing an immature egg. One dominant follicle usually becomes selected to mature and release an egg during ovulation. Estrogen levels rise as the dominant follicle grows, causing the endometrium to thicken in preparation for a potential pregnancy.

3. Luteal phase: Following ovulation, the ruptured follicle transforms into the corpus luteum, which produces progesterone and estrogen to further support the endometrial thickening. If fertilization does not occur within approximately 24 hours after ovulation, the corpus luteum will degenerate, leading to a decline in hormone levels. This drop triggers the onset of menstruation, initiating a new menstrual cycle.

Understanding the menstrual cycle is crucial for monitoring reproductive health and planning or preventing pregnancies. Variations in cycle length and symptoms are common among women, but persistent irregularities may indicate underlying medical conditions requiring further evaluation by a healthcare professional.

Estradiol is a type of estrogen, which is a female sex hormone. It is the most potent and dominant form of estrogen in humans. Estradiol plays a crucial role in the development and maintenance of secondary sexual characteristics in women, such as breast development and regulation of the menstrual cycle. It also helps maintain bone density, protect the lining of the uterus, and is involved in cognition and mood regulation.

Estradiol is produced primarily by the ovaries, but it can also be synthesized in smaller amounts by the adrenal glands and fat cells. In men, estradiol is produced from testosterone through a process called aromatization. Abnormal levels of estradiol can contribute to various health issues, such as hormonal imbalances, infertility, osteoporosis, and certain types of cancer.

Progesterone is a steroid hormone that is primarily produced in the ovaries during the menstrual cycle and in pregnancy. It plays an essential role in preparing the uterus for implantation of a fertilized egg and maintaining the early stages of pregnancy. Progesterone works to thicken the lining of the uterus, creating a nurturing environment for the developing embryo.

During the menstrual cycle, progesterone is produced by the corpus luteum, a temporary structure formed in the ovary after an egg has been released from a follicle during ovulation. If pregnancy does not occur, the levels of progesterone will decrease, leading to the shedding of the uterine lining and menstruation.

In addition to its reproductive functions, progesterone also has various other effects on the body, such as helping to regulate the immune system, supporting bone health, and potentially influencing mood and cognition. Progesterone can be administered medically in the form of oral pills, intramuscular injections, or vaginal suppositories for various purposes, including hormone replacement therapy, contraception, and managing certain gynecological conditions.

Luteinizing Hormone (LH) is a glycoprotein hormone, which is primarily produced and released by the anterior pituitary gland. In women, a surge of LH triggers ovulation, the release of an egg from the ovaries during the menstrual cycle. During pregnancy, LH stimulates the corpus luteum to produce progesterone. In men, LH stimulates the testes to produce testosterone. It plays a crucial role in sexual development, reproduction, and maintaining the reproductive system.

Follicle-Stimulating Hormone (FSH) is a glycoprotein hormone secreted and released by the anterior pituitary gland. In females, it promotes the growth and development of ovarian follicles in the ovary, which ultimately leads to the maturation and release of an egg (ovulation). In males, FSH stimulates the testes to produce sperm. It works in conjunction with luteinizing hormone (LH) to regulate reproductive processes. The secretion of FSH is controlled by the hypothalamic-pituitary-gonadal axis and its release is influenced by the levels of gonadotropin-releasing hormone (GnRH), estrogen, inhibin, and androgens.

An ovarian follicle is a fluid-filled sac in the ovary that contains an immature egg or ovum (oocyte). It's a part of the female reproductive system and plays a crucial role in the process of ovulation.

Ovarian follicles start developing in the ovaries during fetal development, but only a small number of them will mature and release an egg during a woman's reproductive years. The maturation process is stimulated by hormones like follicle-stimulating hormone (FSH) and luteinizing hormone (LH).

There are different types of ovarian follicles, including primordial, primary, secondary, and tertiary or Graafian follicles. The Graafian follicle is the mature follicle that ruptures during ovulation to release the egg into the fallopian tube, where it may be fertilized by sperm.

It's important to note that abnormal growth or development of ovarian follicles can lead to conditions like polycystic ovary syndrome (PCOS) and ovarian cancer.

Ovulation is the medical term for the release of a mature egg from an ovary during a woman's menstrual cycle. The released egg travels through the fallopian tube where it may be fertilized by sperm if sexual intercourse has occurred recently. If the egg is not fertilized, it will break down and leave the body along with the uterine lining during menstruation. Ovulation typically occurs around day 14 of a 28-day menstrual cycle, but the timing can vary widely from woman to woman and even from cycle to cycle in the same woman.

During ovulation, there are several physical changes that may occur in a woman's body, such as an increase in basal body temperature, changes in cervical mucus, and mild cramping or discomfort on one side of the lower abdomen (known as mittelschmerz). These symptoms can be used to help predict ovulation and improve the chances of conception.

It's worth noting that some medical conditions, such as polycystic ovary syndrome (PCOS) or premature ovarian failure, may affect ovulation and make it difficult for a woman to become pregnant. In these cases, medical intervention may be necessary to help promote ovulation and increase the chances of conception.

Pregnanediol is a steroid hormone that is produced as a metabolite of progesterone. It is primarily used as a biomarker to measure the exposure to progesterone, particularly in cases where progesterone levels need to be monitored, such as during pregnancy or in certain medical conditions. Pregnanediol can be measured in urine, blood, or other bodily fluids and is often used in clinical and research settings to assess hormonal status. It is important to note that pregnanediol itself does not have any known physiological effects on the body, but rather serves as an indicator of progesterone levels.

An ovary is a part of the female reproductive system in which ova or eggs are produced through the process of oogenesis. They are a pair of solid, almond-shaped structures located one on each side of the uterus within the pelvic cavity. Each ovary measures about 3 to 5 centimeters in length and weighs around 14 grams.

The ovaries have two main functions: endocrine (hormonal) function and reproductive function. They produce and release eggs (ovulation) responsible for potential fertilization and development of an embryo/fetus during pregnancy. Additionally, they are essential in the production of female sex hormones, primarily estrogen and progesterone, which regulate menstrual cycles, sexual development, and reproduction.

During each menstrual cycle, a mature egg is released from one of the ovaries into the fallopian tube, where it may be fertilized by sperm. If not fertilized, the egg, along with the uterine lining, will be shed, leading to menstruation.

Estrus is a term used in veterinary medicine to describe the physiological and behavioral state of female mammals that are ready to mate and conceive. It refers to the period of time when the female's reproductive system is most receptive to fertilization.

During estrus, the female's ovaries release one or more mature eggs (ovulation) into the fallopian tubes, where they can be fertilized by sperm from a male. This phase of the estrous cycle is often accompanied by changes in behavior and physical appearance, such as increased vocalization, restlessness, and swelling of the genital area.

The duration and frequency of estrus vary widely among different species of mammals. In some animals, such as dogs and cats, estrus occurs regularly at intervals of several weeks or months, while in others, such as cows and mares, it may only occur once or twice a year.

It's important to note that the term "estrus" is not used to describe human reproductive physiology. In humans, the equivalent phase of the menstrual cycle is called ovulation.

Premenstrual Syndrome (PMS) is a complex of symptoms that occur in the latter part of the luteal phase (the second half) of the menstrual cycle, typically starting 5-11 days before the onset of menses, and remitting shortly after the onset of menstruation. The symptoms can be physical, psychological, or behavioral and vary from mild to severe. They include but are not limited to: bloating, breast tenderness, cramps, headaches, mood swings, irritability, depression, anxiety, fatigue, changes in appetite, and difficulty concentrating.

The exact cause of PMS is not known, but it appears to be related to hormonal changes during the menstrual cycle, particularly fluctuations in estrogen and progesterone levels. Some women may be more susceptible to these hormonal shifts due to genetic factors, neurotransmitter imbalances, or other health conditions.

Treatment for PMS often involves a combination of lifestyle changes (such as regular exercise, stress management, and dietary modifications), over-the-counter pain relievers, and, in some cases, hormonal medications or antidepressants. It's important to consult with a healthcare provider for an accurate diagnosis and treatment plan.

Menstruation is the regular, cyclical shedding of the uterine lining (endometrium) in women and female individuals of reproductive age, accompanied by the discharge of blood and other materials from the vagina. It typically occurs every 21 to 35 days and lasts for approximately 2-7 days. This process is a part of the menstrual cycle, which is under the control of hormonal fluctuations involving follicle-stimulating hormone (FSH), luteinizing hormone (LH), estrogen, and progesterone.

The menstrual cycle can be divided into three main phases:

1. Menstruation phase: The beginning of the cycle is marked by the start of menstrual bleeding, which signals the breakdown and shedding of the endometrium due to the absence of pregnancy and low levels of estrogen and progesterone. This phase typically lasts for 2-7 days.

2. Proliferative phase: After menstruation, under the influence of rising estrogen levels, the endometrium starts to thicken and regenerate. The uterine lining becomes rich in blood vessels and glands, preparing for a potential pregnancy. This phase lasts from day 5 until around day 14 of an average 28-day cycle.

3. Secretory phase: Following ovulation (release of an egg from the ovaries), which usually occurs around day 14, increased levels of progesterone cause further thickening and maturation of the endometrium. The glands in the lining produce nutrients to support a fertilized egg. If pregnancy does not occur, both estrogen and progesterone levels will drop, leading to menstruation and the start of a new cycle.

Understanding menstruation is essential for monitoring reproductive health, identifying potential issues such as irregular periods or menstrual disorders, and planning family planning strategies.

Inhibins are a group of protein hormones that play a crucial role in regulating the function of the reproductive system, specifically by inhibiting the production of follicle-stimulating hormone (FSH) in the pituitary gland. They are produced and secreted primarily by the granulosa cells in the ovaries of females and Sertoli cells in the testes of males.

Inhibins consist of two subunits, an alpha subunit, and a beta subunit, which can be further divided into two types: inhibin A and inhibin B. Inhibin A is primarily produced by the granulosa cells of developing follicles in the ovary, while inhibin B is mainly produced by the Sertoli cells in the testes.

By regulating FSH production, inhibins help control the development and maturation of ovarian follicles in females and spermatogenesis in males. Abnormal levels of inhibins have been associated with various reproductive disorders, including polycystic ovary syndrome (PCOS) and certain types of cancer.

Gonadotropin-Releasing Hormone (GnRH), also known as Luteinizing Hormone-Releasing Hormone (LHRH), is a hormonal peptide consisting of 10 amino acids. It is produced and released by the hypothalamus, an area in the brain that links the nervous system to the endocrine system via the pituitary gland.

GnRH plays a crucial role in regulating reproduction and sexual development through its control of two gonadotropins: follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These gonadotropins, in turn, stimulate the gonads (ovaries or testes) to produce sex steroids and eggs or sperm.

GnRH acts on the anterior pituitary gland by binding to its specific receptors, leading to the release of FSH and LH. The hypothalamic-pituitary-gonadal axis is under negative feedback control, meaning that when sex steroid levels are high, they inhibit the release of GnRH, which subsequently decreases FSH and LH secretion.

GnRH agonists and antagonists have clinical applications in various medical conditions, such as infertility treatments, precocious puberty, endometriosis, uterine fibroids, prostate cancer, and hormone-responsive breast cancer.

Ovulation induction is a medical procedure that involves the stimulation of ovulation (the release of an egg from the ovaries) in women who have difficulties conceiving due to ovulatory disorders. This is typically achieved through the use of medications such as clomiphene citrate or gonadotropins, which promote the development and maturation of follicles in the ovaries containing eggs. The process is closely monitored through regular ultrasounds and hormone tests to ensure appropriate response and minimize the risk of complications like multiple pregnancies. Ovulation induction may be used as a standalone treatment or in conjunction with other assisted reproductive technologies (ART), such as intrauterine insemination (IUI) or in vitro fertilization (IVF).

The estrous cycle is the reproductive cycle in certain mammals, characterized by regular changes in the reproductive tract and behavior, which are regulated by hormonal fluctuations. It is most commonly observed in non-primate mammals such as dogs, cats, cows, pigs, and horses.

The estrous cycle consists of several stages:

1. Proestrus: This stage lasts for a few days and is characterized by the development of follicles in the ovaries and an increase in estrogen levels. During this time, the female may show signs of sexual receptivity, but will not allow mating to occur.
2. Estrus: This is the period of sexual receptivity, during which the female allows mating to take place. It typically lasts for a few days and is marked by a surge in luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which triggers ovulation.
3. Metestrus: This stage follows ovulation and is characterized by the formation of a corpus luteum, a structure that produces progesterone to support pregnancy. If fertilization does not occur, the corpus luteum will eventually regress, leading to the next phase.
4. Diestrus: This is the final stage of the estrous cycle and can last for several weeks or months. During this time, the female's reproductive tract returns to its resting state, and she is not sexually receptive. If pregnancy has occurred, the corpus luteum will continue to produce progesterone until the placenta takes over this function later in pregnancy.

It's important to note that the human menstrual cycle is different from the estrous cycle. While both cycles involve hormonal fluctuations and changes in the reproductive tract, the menstrual cycle includes a shedding of the uterine lining (menstruation) if fertilization does not occur, which is not a feature of the estrous cycle.

Follicular fluid is the fluid that accumulates within the follicle (a small sac or cyst) in the ovary where an egg matures. This fluid contains various chemicals, hormones, and proteins that support the growth and development of the egg cell. It also contains metabolic waste products and other substances from the granulosa cells (the cells that surround the egg cell within the follicle). Follicular fluid is often analyzed in fertility treatments and studies as it can provide valuable information about the health and viability of the egg cell.

I apologize, but "sheep" is not a term that has a medical definition. It is a common animal with the scientific name Ovis aries. If you have any medical or health-related questions, I would be happy to try and help answer those for you.

The Fallopian tubes, also known as uterine tubes or oviducts, are a pair of slender tubular structures in the female reproductive system. They play a crucial role in human reproduction by providing a passageway for the egg (ovum) from the ovary to the uterus (womb).

Each Fallopian tube is typically around 7.6 to 10 centimeters long and consists of four parts: the interstitial part, the isthmus, the ampulla, and the infundibulum. The fimbriated end of the infundibulum, which resembles a fringe or frill, surrounds and captures the released egg from the ovary during ovulation.

Fertilization usually occurs in the ampulla when sperm meets the egg after sexual intercourse. Once fertilized, the zygote (fertilized egg) travels through the Fallopian tube toward the uterus for implantation and further development. The cilia lining the inner surface of the Fallopian tubes help propel the egg and the zygote along their journey.

In some cases, abnormalities or blockages in the Fallopian tubes can lead to infertility or ectopic pregnancies, which are pregnancies that develop outside the uterus, typically within the Fallopian tube itself.

Gonadal steroid hormones, also known as gonadal sex steroids, are hormones that are produced and released by the gonads (i.e., ovaries in women and testes in men). These hormones play a critical role in the development and maintenance of secondary sexual characteristics, reproductive function, and overall health.

The three main classes of gonadal steroid hormones are:

1. Androgens: These are male sex hormones that are primarily produced by the testes but also produced in smaller amounts by the ovaries and adrenal glands. The most well-known androgen is testosterone, which plays a key role in the development of male secondary sexual characteristics such as facial hair, deepening of the voice, and increased muscle mass.
2. Estrogens: These are female sex hormones that are primarily produced by the ovaries but also produced in smaller amounts by the adrenal glands. The most well-known estrogen is estradiol, which plays a key role in the development of female secondary sexual characteristics such as breast development and the menstrual cycle.
3. Progestogens: These are hormones that are produced by the ovaries during the second half of the menstrual cycle and play a key role in preparing the uterus for pregnancy. The most well-known progestogen is progesterone, which also plays a role in maintaining pregnancy and regulating the menstrual cycle.

Gonadal steroid hormones can have significant effects on various physiological processes, including bone density, cognitive function, mood, and sexual behavior. Disorders of gonadal steroid hormone production or action can lead to a range of health problems, including infertility, osteoporosis, and sexual dysfunction.

Gonadotropins are hormones that stimulate the gonads (sex glands) to produce sex steroids and gametes (sex cells). In humans, there are two main types of gonadotropins: follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which are produced and released by the anterior pituitary gland.

FSH plays a crucial role in the development and maturation of ovarian follicles in females and sperm production in males. LH triggers ovulation in females, causing the release of a mature egg from the ovary, and stimulates testosterone production in males.

Gonadotropins are often used in medical treatments to stimulate the gonads, such as in infertility therapies where FSH and LH are administered to induce ovulation or increase sperm production.

Gonadotropins are hormones produced and released by the anterior pituitary gland, a small endocrine gland located at the base of the brain. These hormones play crucial roles in regulating reproduction and sexual development. There are two main types of gonadotropins:

1. Follicle-Stimulating Hormone (FSH): FSH is essential for the growth and development of follicles in the ovaries (in females) or sperm production in the testes (in males). In females, FSH stimulates the maturation of eggs within the follicles.
2. Luteinizing Hormone (LH): LH triggers ovulation in females, causing the release of a mature egg from the dominant follicle. In males, LH stimulates the production and secretion of testosterone in the testes.

Together, FSH and LH work synergistically to regulate various aspects of reproductive function and sexual development. Their secretion is controlled by the hypothalamus, which releases gonadotropin-releasing hormone (GnRH) to stimulate the production and release of FSH and LH from the anterior pituitary gland.

Abnormal levels of gonadotropins can lead to various reproductive disorders, such as infertility or menstrual irregularities in females and issues related to sexual development or function in both sexes. In some cases, synthetic forms of gonadotropins may be used clinically to treat these conditions or for assisted reproductive technologies (ART).

Androstenedione is a steroid hormone produced by the adrenal glands, ovaries, and testes. It is a precursor to both male and female sex hormones, including testosterone and estrogen. In the adrenal glands, it is produced from cholesterol through a series of biochemical reactions involving several enzymes. Androstenedione can also be converted into other steroid hormones, such as dehydroepiandrosterone (DHEA) and estrone.

In the body, androstenedione plays an important role in the development and maintenance of secondary sexual characteristics, such as facial hair and a deep voice in men, and breast development and menstrual cycles in women. It also contributes to bone density, muscle mass, and overall physical strength.

Androstenedione is available as a dietary supplement and has been marketed as a way to boost athletic performance and increase muscle mass. However, its effectiveness for these purposes is not supported by scientific evidence, and it may have harmful side effects when taken in high doses or for extended periods of time. Additionally, the use of androstenedione as a dietary supplement is banned by many sports organizations, including the International Olympic Committee and the National Collegiate Athletic Association.

Anti-Mullerian Hormone (AMH) is a glycoprotein hormone that belongs to the transforming growth factor-beta (TGF-β) family. It is primarily produced by the granulosa cells of developing follicles in the ovaries of females. AMH plays an essential role in female reproductive physiology, as it inhibits the recruitment and further development of primordial follicles, thereby regulating the size of the primordial follicle pool and the onset of puberty.

AMH levels are often used as a biomarker for ovarian reserve assessment in women. High AMH levels indicate a larger ovarian reserve, while low levels suggest a decreased reserve, which may be associated with reduced fertility or an earlier onset of menopause. Additionally, measuring AMH levels can help predict the response to ovarian stimulation during assisted reproductive technologies (ART) such as in vitro fertilization (IVF).

Anovulation is a medical condition in which there is a failure to ovulate, or release a mature egg from the ovaries, during a menstrual cycle. This can occur due to various reasons such as hormonal imbalances, polycystic ovary syndrome (PCOS), premature ovarian failure, excessive exercise, stress, low body weight, or certain medications. Anovulation is common in women with irregular menstrual cycles and can cause infertility if left untreated. In some cases, anovulation may be treated with medication to stimulate ovulation.

Ovarian function tests are a series of diagnostic exams used to assess the health and functionality of the ovaries. These tests can help determine the remaining egg supply (ovarian reserve), evaluate hormone production, and identify any structural abnormalities. Commonly used ovarian function tests include:

1. Hormonal assays: Measuring levels of hormones such as follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, and anti-Müllerian hormone (AMH) in the blood can provide information about ovarian function and egg supply.

2. Transvaginal ultrasound: This imaging technique is used to visualize the ovaries and assess their size, shape, and follicle development, which can indicate ovarian reserve and response to hormonal stimulation.

3. Clomiphene citrate challenge test (CCCT): This test involves measuring FSH levels on day 3 of the menstrual cycle and then again after administering clomiphene citrate, a fertility medication, on days 5-9. An abnormal response may suggest decreased ovarian function.

4. Gonadotropin-releasing hormone (GnRH) agonist stimulation test: This test evaluates the ovaries' ability to respond to GnRH, which regulates FSH and LH release. A suboptimal response may indicate reduced ovarian function.

5. Ovarian biopsy: Though rarely performed, an ovarian biopsy can provide direct information about the number and quality of follicles and eggs present in the ovary.

These tests are often used in conjunction to provide a comprehensive assessment of ovarian function, particularly in women experiencing infertility, menopause, or those undergoing assisted reproductive technologies (ART).

Menstruation disturbances, also known as menstrual disorders, refer to any irregularities or abnormalities in a woman's menstrual cycle. These disturbances can manifest in various ways, including:

1. Amenorrhea: The absence of menstrual periods for three consecutive cycles or more in women of reproductive age.
2. Oligomenorrhea: Infrequent or light menstrual periods that occur at intervals greater than 35 days.
3. Dysmenorrhea: Painful menstruation, often accompanied by cramping, pelvic pain, and other symptoms that can interfere with daily activities.
4. Menorrhagia: Heavy or prolonged menstrual periods that last longer than seven days or result in excessive blood loss, leading to anemia or other health complications.
5. Polymenorrhea: Abnormally frequent menstrual periods that occur at intervals of 21 days or less.
6. Metrorrhagia: Irregular and unpredictable vaginal bleeding between expected menstrual periods, which can be caused by various factors such as hormonal imbalances, infections, or structural abnormalities.

Menstruation disturbances can have significant impacts on a woman's quality of life, fertility, and overall health. They may result from various underlying conditions, including hormonal imbalances, polycystic ovary syndrome (PCOS), thyroid disorders, uterine fibroids, endometriosis, or sexually transmitted infections. Proper diagnosis and treatment of the underlying cause are essential for managing menstruation disturbances effectively.

Fertilization in vitro, also known as in-vitro fertilization (IVF), is a medical procedure where an egg (oocyte) and sperm are combined in a laboratory dish to facilitate fertilization. The fertilized egg (embryo) is then transferred to a uterus with the hope of establishing a successful pregnancy. This procedure is often used when other assisted reproductive technologies have been unsuccessful or are not applicable, such as in cases of blocked fallopian tubes, severe male factor infertility, and unexplained infertility. The process involves ovarian stimulation, egg retrieval, fertilization, embryo culture, and embryo transfer. In some cases, additional techniques such as intracytoplasmic sperm injection (ICSI) or preimplantation genetic testing (PGT) may be used to increase the chances of success.

Ovulation prediction is the process of determining the most fertile period during a woman's menstrual cycle, specifically the time when ovulation is likely to occur. This is typically done through various methods and tests that detect the surge in luteinizing hormone (LH) levels, which occurs 24-36 hours prior to ovulation. These methods may include urine test kits, saliva ferning tests, or electronic fertility monitors. Accurately predicting ovulation can help individuals or couples trying to conceive or avoid pregnancy through natural family planning methods.

Estrone is a type of estrogen, which is a female sex hormone. It's one of the three major naturally occurring estrogens in women, along with estradiol and estriol. Estrone is weaker than estradiol but has a longer half-life, meaning it remains active in the body for a longer period of time.

Estrone is produced primarily in the ovaries, adrenal glands, and fat tissue. In postmenopausal women, when the ovaries stop producing estradiol, estrone becomes the dominant form of estrogen. It plays a role in maintaining bone density, regulating the menstrual cycle, and supporting the development and maintenance of female sexual characteristics.

Like other forms of estrogen, estrone can also have effects on various tissues throughout the body, including the brain, heart, and breast tissue. Abnormal levels of estrone, either too high or too low, can contribute to a variety of health issues, such as osteoporosis, menstrual irregularities, and increased risk of certain types of cancer.

Female infertility is a condition characterized by the inability to conceive after 12 months or more of regular, unprotected sexual intercourse or the inability to carry a pregnancy to a live birth. The causes of female infertility can be multifactorial and may include issues with ovulation, damage to the fallopian tubes or uterus, endometriosis, hormonal imbalances, age-related factors, and other medical conditions.

Some common causes of female infertility include:

1. Ovulation disorders: Conditions such as polycystic ovary syndrome (PCOS), thyroid disorders, premature ovarian failure, and hyperprolactinemia can affect ovulation and lead to infertility.
2. Damage to the fallopian tubes: Pelvic inflammatory disease, endometriosis, or previous surgeries can cause scarring and blockages in the fallopian tubes, preventing the egg and sperm from meeting.
3. Uterine abnormalities: Structural issues with the uterus, such as fibroids, polyps, or congenital defects, can interfere with implantation and pregnancy.
4. Age-related factors: As women age, their fertility declines due to a decrease in the number and quality of eggs.
5. Other medical conditions: Certain medical conditions, such as diabetes, celiac disease, and autoimmune disorders, can contribute to infertility.

In some cases, female infertility can be treated with medications, surgery, or assisted reproductive technologies (ART) like in vitro fertilization (IVF). A thorough evaluation by a healthcare professional is necessary to determine the underlying cause and develop an appropriate treatment plan.

Premenopause is not a formal medical term, but it's often informally used to refer to the time period in a woman's life leading up to menopause. During this stage, which can last for several years, hormonal changes begin to occur in preparation for menopause. The ovaries start to produce less estrogen and progesterone, which can lead to various symptoms such as irregular periods, hot flashes, mood swings, and sleep disturbances. However, it's important to note that not all women will experience these symptoms.

The official medical term for the stage when a woman's period becomes irregular and less frequent, but hasn't stopped completely, is perimenopause. This stage typically lasts from two to eight years and ends with menopause, which is defined as the point when a woman has not had a period for 12 consecutive months. After menopause, women enter postmenopause.

The corpus luteum is a temporary endocrine structure that forms in the ovary after an oocyte (egg) has been released from a follicle during ovulation. It's formed by the remaining cells of the ruptured follicle, which transform into large, hormone-secreting cells.

The primary function of the corpus luteum is to produce progesterone and, to a lesser extent, estrogen during the menstrual cycle or pregnancy. Progesterone plays a crucial role in preparing the uterus for potential implantation of a fertilized egg and maintaining the early stages of pregnancy. If pregnancy does not occur, the corpus luteum will typically degenerate and stop producing hormones after approximately 10-14 days, leading to menstruation.

However, if pregnancy occurs, the developing embryo starts to produce human chorionic gonadotropin (hCG), which signals the corpus luteum to continue secreting progesterone and estrogen until the placenta takes over hormonal production, usually around the end of the first trimester.

Chorionic Gonadotropin (hCG) is a hormone that is produced during pregnancy. It is produced by the placenta after implantation of the fertilized egg in the uterus. The main function of hCG is to prevent the disintegration of the corpus luteum, which is a temporary endocrine structure that forms in the ovary after ovulation and produces progesterone during early pregnancy. Progesterone is essential for maintaining the lining of the uterus and supporting the pregnancy.

hCG can be detected in the blood or urine as early as 10 days after conception, and its levels continue to rise throughout the first trimester of pregnancy. In addition to its role in maintaining pregnancy, hCG is also used as a clinical marker for pregnancy and to monitor certain medical conditions such as gestational trophoblastic diseases.

Clomiphene is a medication that is primarily used to treat infertility in women. It is an ovulatory stimulant, which means that it works by stimulating the development and release of mature eggs from the ovaries (a process known as ovulation). Clomiphene is a selective estrogen receptor modulator (SERM), which means that it binds to estrogen receptors in the body and blocks the effects of estrogen in certain tissues, while enhancing the effects of estrogen in others.

In the ovary, clomiphene works by blocking the negative feedback effect of estrogen on the hypothalamus and pituitary gland, which results in an increase in the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones stimulate the growth and development of ovarian follicles, which contain eggs. As the follicles grow and mature, they produce increasing amounts of estrogen, which eventually triggers a surge in LH that leads to ovulation.

Clomiphene is typically taken orally for 5 days, starting on the 3rd, 4th, or 5th day of the menstrual cycle. The dosage may be adjusted based on the patient's response to treatment. Common side effects of clomiphene include hot flashes, mood changes, breast tenderness, and ovarian hyperstimulation syndrome (OHSS), which is a potentially serious complication characterized by the enlargement of the ovaries and the accumulation of fluid in the abdomen.

It's important to note that clomiphene may not be suitable for everyone, and its use should be carefully monitored by a healthcare provider. Women with certain medical conditions, such as liver disease, thyroid disorders, or uterine fibroids, may not be able to take clomiphene. Additionally, women who become pregnant while taking clomiphene have an increased risk of multiple pregnancies (e.g., twins or triplets), which can pose additional risks to both the mother and the fetuses.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

Ovulation detection refers to the process of identifying the time period during which an ovary releases an oocyte (mature egg) from its follicle, ready for fertilization. This is a crucial aspect of reproductive health and assisted reproduction technologies (ART), such as in vitro fertilization (IVF).

There are several methods to detect ovulation, including:

1. Ovulation Predictor Kits (OPKs): These are home-use test kits that detect the surge of luteinizing hormone (LH) in urine, which occurs 24-36 hours prior to ovulation.
2. Basal Body Temperature (BBT) Charting: This involves tracking and recording daily basal body temperature (the lowest temperature attained by the body during rest), as it tends to rise slightly after ovulation due to increased progesterone levels.
3. Hormonal Monitoring: Blood tests can be used to measure hormone levels, such as estrogen and progesterone, throughout a menstrual cycle to detect ovulation.
4. Transvaginal Ultrasound: This imaging technique is often used in clinical settings to monitor follicular development and determine the exact time of ovulation by observing changes in the ovarian follicle and endometrial lining.
5. Saliva Ferning Tests: A microscope is used to examine the patterns formed by dried saliva, which can indicate increased estrogen levels prior to ovulation.

Accurate ovulation detection helps individuals or couples trying to conceive optimize their chances of success and provides valuable information for healthcare providers in managing reproductive health issues.

The endometrium is the innermost layer of the uterus, which lines the uterine cavity and has a critical role in the menstrual cycle and pregnancy. It is composed of glands and blood vessels that undergo cyclic changes under the influence of hormones, primarily estrogen and progesterone. During the menstrual cycle, the endometrium thickens in preparation for a potential pregnancy. If fertilization does not occur, it will break down and be shed, resulting in menstruation. In contrast, if implantation takes place, the endometrium provides essential nutrients to support the developing embryo and placenta throughout pregnancy.

Cloprostenol is a synthetic prostaglandin analog used primarily in veterinary medicine for the treatment and prevention of various conditions. The main therapeutic uses of Cloprostenol include:

1. Induction of parturition (labor) in cows, helping to synchronize calving in managed herds.
2. Termination of pregnancy in cattle, especially in cases where the fetus is nonviable or the pregnancy poses a risk to the animal's health.
3. Treatment of uterine and oviductal disorders, such as pyometra (infection of the uterus) and salpingitis (inflammation of the oviduct), in cattle and pigs.
4. Prevention of postpartum disorders, like endometritis (inflammation of the lining of the uterus) and mastitis (inflammation of the mammary glands), by promoting uterine involution and improving overall reproductive performance in cattle.
5. Control of estrus (heat) in cattle, as an aid in estrous synchronization programs for artificial insemination.

Cloprostenol is available in various formulations, such as intramuscular or subcutaneous injectable solutions, and is typically administered by a veterinarian or trained personnel. It is important to note that the use of Cloprostenol and other prostaglandin analogs should be carried out under the guidance and supervision of a veterinary professional, as improper usage can lead to adverse effects or complications.

Superovulation, also known as controlled ovarian stimulation (COS), refers to the process of inducing the development and release of multiple mature ova (eggs) from the ovaries during a single reproductive cycle. This is achieved through the administration of exogenous gonadotropins or other fertility medications, which stimulate the ovarian follicles to grow and mature beyond the normal number. Superovulation is commonly used in assisted reproductive technologies (ART) such as in vitro fertilization (IVF) to increase the chances of successful conception by obtaining a larger number of ova for fertilization and embryo transfer.

Hormones are defined as chemical messengers that are produced by endocrine glands or specialized cells and are transported through the bloodstream to tissues and organs, where they elicit specific responses. They play crucial roles in regulating various physiological processes such as growth, development, metabolism, reproduction, and mood. Examples of hormones include insulin, estrogen, testosterone, adrenaline, and thyroxine.

Follicular atresia is a physiological process that occurs in the ovary, where follicles (fluid-filled sacs containing immature eggs or oocytes) undergo degeneration and disappearance. This process begins after the primordial follicle stage and continues throughout a woman's reproductive years. At birth, a female has approximately 1 to 2 million primordial follicles, but only about 400 of these will mature and release an egg during her lifetime. The rest undergo atresia, which is a natural process that helps regulate the number of available eggs and maintain hormonal balance within the body.

The exact mechanisms that trigger follicular atresia are not fully understood, but it is believed to be influenced by various factors such as hormonal imbalances, oxidative stress, and apoptosis (programmed cell death). In some cases, accelerated or excessive follicular atresia can lead to infertility or early menopause.

Postcoital contraceptives, also known as emergency contraceptives, are methods used to prevent pregnancy after sexual intercourse. The synthetic postcoital contraceptive is a type of emergency contraception that contains synthetic hormones, such as levonorgestrel or ulipristal acetate. These hormones work by preventing ovulation, inhibiting fertilization, or altering the lining of the uterus to prevent implantation of a fertilized egg.

The most common synthetic postcoital contraceptive is the levonorgestrel emergency contraceptive pill (LNG-ECP), which contains a high dose of the synthetic hormone levonorgestrel. It is usually taken as a single dose within 72 hours (3 days) of unprotected sexual intercourse, but it is most effective when taken as soon as possible after intercourse.

Another synthetic postcoital contraceptive is ulipristal acetate, which is also taken as a single dose but within 120 hours (5 days) of unprotected sexual intercourse. Ulipristal acetate works by delaying ovulation and preventing the fertilized egg from implanting in the uterus.

It's important to note that synthetic postcoital contraceptives are not intended for regular use as a primary form of birth control, but rather as an emergency measure to prevent pregnancy after unprotected sexual intercourse or contraceptive failure. They should be used under the guidance of a healthcare provider and should not be used in place of regular contraception.

The uterus, also known as the womb, is a hollow, muscular organ located in the female pelvic cavity, between the bladder and the rectum. It has a thick, middle layer called the myometrium, which is composed of smooth muscle tissue, and an inner lining called the endometrium, which provides a nurturing environment for the fertilized egg to develop into a fetus during pregnancy.

The uterus is where the baby grows and develops until it is ready for birth through the cervix, which is the lower, narrow part of the uterus that opens into the vagina. The uterus plays a critical role in the menstrual cycle as well, by shedding its lining each month if pregnancy does not occur.

Ovariectomy is a surgical procedure in which one or both ovaries are removed. It is also known as "ovary removal" or "oophorectomy." This procedure is often performed as a treatment for various medical conditions, including ovarian cancer, endometriosis, uterine fibroids, and pelvic pain. Ovariectomy can also be part of a larger surgical procedure called an hysterectomy, in which the uterus is also removed.

In some cases, an ovariectomy may be performed as a preventative measure for individuals at high risk of developing ovarian cancer. This is known as a prophylactic ovariectomy. After an ovariectomy, a person will no longer have menstrual periods and will be unable to become pregnant naturally. Hormone replacement therapy may be recommended in some cases to help manage symptoms associated with the loss of hormones produced by the ovaries.

Luteolysis is the physiological process that leads to the breakdown and regression of the corpus luteum, a temporary endocrine structure in the ovary that forms after ovulation. The corpus luteum produces progesterone, which supports pregnancy in mammals. If pregnancy does not occur, luteolysis takes place approximately 10-14 days after ovulation in humans and is characterized by the degeneration of the corpus luteum, decreased production of progesterone, and the initiation of the menstrual cycle or the onset of a new reproductive cycle.

The primary event that triggers luteolysis is the release of prostaglandin F2α (PGF2α) from the uterus, which reaches the corpus luteum through the systemic circulation and causes vasoconstriction, reduced blood flow, and structural damage to the corpus luteum. This results in a decline in progesterone levels, which ultimately leads to menstruation or the onset of a new reproductive cycle.

In summary, luteolysis is a crucial process in the female reproductive system that regulates hormonal balance and prepares the body for a new reproductive cycle when pregnancy does not occur.

The pituitary gland is a small, endocrine gland located at the base of the brain, in the sella turcica of the sphenoid bone. It is often called the "master gland" because it controls other glands and makes the hormones that trigger many body functions. The pituitary gland measures about 0.5 cm in height and 1 cm in width, and it weighs approximately 0.5 grams.

The pituitary gland is divided into two main parts: the anterior lobe (adenohypophysis) and the posterior lobe (neurohypophysis). The anterior lobe is further divided into three zones: the pars distalis, pars intermedia, and pars tuberalis. Each part of the pituitary gland has distinct functions and produces different hormones.

The anterior pituitary gland produces and releases several important hormones, including:

* Growth hormone (GH), which regulates growth and development in children and helps maintain muscle mass and bone strength in adults.
* Thyroid-stimulating hormone (TSH), which controls the production of thyroid hormones by the thyroid gland.
* Adrenocorticotropic hormone (ACTH), which stimulates the adrenal glands to produce cortisol and other steroid hormones.
* Follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which regulate reproductive function in both males and females.
* Prolactin, which stimulates milk production in pregnant and lactating women.

The posterior pituitary gland stores and releases two hormones that are produced by the hypothalamus:

* Antidiuretic hormone (ADH), which helps regulate water balance in the body by controlling urine production.
* Oxytocin, which stimulates uterine contractions during childbirth and milk release during breastfeeding.

Overall, the pituitary gland plays a critical role in maintaining homeostasis and regulating various bodily functions, including growth, development, metabolism, and reproductive function.

Female fertility agents are medications or treatments that are used to enhance or restore female fertility. They can work in various ways such as stimulating ovulation, improving the quality of eggs, facilitating the implantation of a fertilized egg in the uterus, or addressing issues related to the reproductive system.

Some examples of female fertility agents include:

1. Clomiphene citrate (Clomid, Serophene): This medication stimulates ovulation by causing the pituitary gland to release more follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
2. Gonadotropins: These are hormonal medications that contain FSH and LH, which stimulate the ovaries to produce mature eggs. Examples include human menopausal gonadotropin (hMG) and follicle-stimulating hormone (FSH).
3. Letrozole (Femara): This medication is an aromatase inhibitor that can be used off-label to stimulate ovulation in women who do not respond to clomiphene citrate.
4. Metformin (Glucophage): This medication is primarily used to treat type 2 diabetes, but it can also improve fertility in women with polycystic ovary syndrome (PCOS) by regulating insulin levels and promoting ovulation.
5. Bromocriptine (Parlodel): This medication is used to treat infertility caused by hyperprolactinemia, a condition characterized by high levels of prolactin in the blood.
6. Assisted reproductive technologies (ART): These include procedures such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete intrafallopian transfer (GIFT). They involve manipulating eggs and sperm outside the body to facilitate fertilization and implantation.

It is important to consult with a healthcare provider or reproductive endocrinologist to determine the most appropriate fertility agent for individual needs, as these medications can have side effects and potential risks.

Amenorrhea is a medical condition characterized by the absence or cessation of menstrual periods in women of reproductive age. It can be categorized as primary amenorrhea, when a woman who has not yet had her first period at the expected age (usually around 16 years old), or secondary amenorrhea, when a woman who has previously had regular periods stops getting them for six months or more.

There are various causes of amenorrhea, including hormonal imbalances, pregnancy, breastfeeding, menopause, extreme weight loss or gain, eating disorders, intense exercise, stress, chronic illness, tumors, and certain medications or medical treatments. In some cases, amenorrhea may indicate an underlying medical condition that requires further evaluation and treatment.

Amenorrhea can have significant impacts on a woman's health and quality of life, including infertility, bone loss, and emotional distress. Therefore, it is essential to consult with a healthcare provider if you experience amenorrhea or missed periods to determine the underlying cause and develop an appropriate treatment plan.

Radioimmunoassay (RIA) is a highly sensitive analytical technique used in clinical and research laboratories to measure concentrations of various substances, such as hormones, vitamins, drugs, or tumor markers, in biological samples like blood, urine, or tissues. The method relies on the specific interaction between an antibody and its corresponding antigen, combined with the use of radioisotopes to quantify the amount of bound antigen.

In a typical RIA procedure, a known quantity of a radiolabeled antigen (also called tracer) is added to a sample containing an unknown concentration of the same unlabeled antigen. The mixture is then incubated with a specific antibody that binds to the antigen. During the incubation period, the antibody forms complexes with both the radiolabeled and unlabeled antigens.

After the incubation, the unbound (free) radiolabeled antigen is separated from the antibody-antigen complexes, usually through a precipitation or separation step involving centrifugation, filtration, or chromatography. The amount of radioactivity in the pellet (containing the antibody-antigen complexes) is then measured using a gamma counter or other suitable radiation detection device.

The concentration of the unlabeled antigen in the sample can be determined by comparing the ratio of bound to free radiolabeled antigen in the sample to a standard curve generated from known concentrations of unlabeled antigen and their corresponding bound/free ratios. The higher the concentration of unlabeled antigen in the sample, the lower the amount of radiolabeled antigen that will bind to the antibody, resulting in a lower bound/free ratio.

Radioimmunoassays offer high sensitivity, specificity, and accuracy, making them valuable tools for detecting and quantifying low levels of various substances in biological samples. However, due to concerns about radiation safety and waste disposal, alternative non-isotopic immunoassay techniques like enzyme-linked immunosorbent assays (ELISAs) have become more popular in recent years.

Hormone antagonists are substances or drugs that block the action of hormones by binding to their receptors without activating them, thereby preventing the hormones from exerting their effects. They can be classified into two types: receptor antagonists and enzyme inhibitors. Receptor antagonists bind directly to hormone receptors and prevent the hormone from binding, while enzyme inhibitors block the production or breakdown of hormones by inhibiting specific enzymes involved in their metabolism. Hormone antagonists are used in the treatment of various medical conditions, such as cancer, hormonal disorders, and cardiovascular diseases.

Testosterone is a steroid hormone that belongs to androsten class of hormones. It is primarily secreted by the Leydig cells in the testes of males and, to a lesser extent, by the ovaries and adrenal glands in females. Testosterone is the main male sex hormone and anabolic steroid. It plays a key role in the development of masculine characteristics, such as body hair and muscle mass, and contributes to bone density, fat distribution, red cell production, and sex drive. In females, testosterone contributes to sexual desire and bone health. Testosterone is synthesized from cholesterol and its production is regulated by luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

Trenbolone Acetate is an esterified form of the synthetic steroid hormone Trenbolone. It is a potent anabolic and androgenic steroid, which is used in veterinary medicine for promoting muscle growth and appetite stimulation in cattle. In human medicine, it is not approved for use but is sometimes misused for its anabolic effects, such as increasing muscle mass, strength, and reducing body fat. It is important to note that the use of Trenbolone Acetate in humans is considered off-label and can lead to serious health consequences, including liver toxicity, cardiovascular issues, and hormonal imbalances.

Progesterone congeners refer to synthetic or naturally occurring compounds that are structurally similar to progesterone, a steroid hormone involved in the menstrual cycle, pregnancy, and embryogenesis. These compounds have similar chemical structures to progesterone and may exhibit similar physiological activities, although they can also have unique properties and uses. Examples of progesterone congeners include various synthetic progestins used in hormonal contraceptives and other medical treatments.

Estrogens are a group of steroid hormones that are primarily responsible for the development and regulation of female sexual characteristics and reproductive functions. They are also present in lower levels in males. The main estrogen hormone is estradiol, which plays a key role in promoting the growth and development of the female reproductive system, including the uterus, fallopian tubes, and breasts. Estrogens also help regulate the menstrual cycle, maintain bone density, and have important effects on the cardiovascular system, skin, hair, and cognitive function.

Estrogens are produced primarily by the ovaries in women, but they can also be produced in smaller amounts by the adrenal glands and fat cells. In men, estrogens are produced from the conversion of testosterone, the primary male sex hormone, through a process called aromatization.

Estrogen levels vary throughout a woman's life, with higher levels during reproductive years and lower levels after menopause. Estrogen therapy is sometimes used to treat symptoms of menopause, such as hot flashes and vaginal dryness, or to prevent osteoporosis in postmenopausal women. However, estrogen therapy also carries risks, including an increased risk of certain cancers, blood clots, and stroke, so it is typically recommended only for women who have a high risk of these conditions.

Secretory rate refers to the amount or volume of a secretion produced by a gland or an organ over a given period of time. It is a measure of the productivity or activity level of the secreting structure. The secretory rate can be quantified for various bodily fluids, such as saliva, sweat, digestive enzymes, hormones, or milk, depending on the context and the specific gland or organ being studied.

In clinical settings, measuring the secretory rate might involve collecting and analyzing samples over a certain duration to estimate the production rate of the substance in question. This information can be helpful in diagnosing conditions related to impaired secretion, monitoring treatment responses, or understanding the physiological adaptations of the body under different circumstances.

Menotropins are a preparation of natural follicle-stimulating hormone (FSH) and luteinizing hormone (LH) derived from the urine of postmenopausal women. They are used in infertility treatment to stimulate the development of multiple follicles in the ovaries, leading to an increased chance of pregnancy through assisted reproductive technologies such as in vitro fertilization (IVF).

Menotropins contain a mixture of FSH and LH in a ratio that is similar to the natural hormone levels found in the human body. The FSH component stimulates the growth and development of follicles in the ovaries, while the LH component triggers ovulation when the follicles have matured.

Menotropins are typically administered by subcutaneous injection and are available under various brand names, such as Menopur and Repronex. The use of menotropins requires careful medical supervision to monitor the response of the ovaries and to minimize the risk of complications such as ovarian hyperstimulation syndrome (OHSS).

Granulosa cells are specialized cells that surround and enclose the developing egg cells (oocytes) in the ovaries. They play a crucial role in the growth, development, and maturation of the follicles (the fluid-filled sacs containing the oocytes) by providing essential nutrients and hormones.

Granulosa cells are responsible for producing estrogen, which supports the development of the endometrium during the menstrual cycle in preparation for a potential pregnancy. They also produce inhibin and activin, two hormones that regulate the function of the pituitary gland and its secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH).

These cells are critical for female reproductive health and fertility. Abnormalities in granulosa cell function can lead to various reproductive disorders, such as polycystic ovary syndrome (PCOS), premature ovarian failure, and infertility.

Follicle-stimulating hormone (FSH) is a glycoprotein hormone produced and released by the anterior pituitary gland. It plays crucial roles in the reproductive system, primarily by promoting the growth and development of follicles in the ovaries or sperm production in the testes.

The FSH molecule consists of two subunits: α (alpha) and β (beta). The α-subunit is common to several glycoprotein hormones, including thyroid-stimulating hormone (TSH), luteinizing hormone (LH), and human chorionic gonadotropin (hCG). In contrast, the β-subunit is unique to each hormone and determines its specific biological activity.

A medical definition of 'Follicle Stimulating Hormone, beta Subunit' refers to the distinct portion of the FSH molecule that is responsible for its particular functions in the body. The β-subunit of FSH enables the hormone to bind to its specific receptors in the gonads and initiate downstream signaling pathways leading to follicular development and spermatogenesis. Any alterations or mutations in the FSH beta subunit can lead to disruptions in reproductive processes, potentially causing infertility or other related disorders.

Buserelin is a synthetic analogue of gonadotropin-releasing hormone (GnRH or LHRH), which is a hormonal drug used in the treatment of various conditions such as endometriosis, uterine fibroids, prostate cancer, and central precocious puberty.

By mimicking the action of natural GnRH, buserelin stimulates the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland, which in turn regulates the production of sex hormones such as estrogen and testosterone.

However, prolonged use of buserelin leads to downregulation of GnRH receptors and a decrease in FSH and LH secretion, resulting in reduced levels of sex hormones. This property is exploited in the treatment of hormone-dependent cancers such as prostate cancer, where reducing testosterone levels can help slow tumor growth.

Buserelin is available in various forms, including nasal sprays, implants, and injectable solutions, and its use should be under the supervision of a healthcare professional due to potential side effects and the need for careful monitoring of hormone levels during treatment.

Polycyctic Ovary Syndrome (PCOS) is a complex endocrine-metabolic disorder characterized by the presence of hyperandrogenism (excess male hormones), ovulatory dysfunction, and polycystic ovaries. The Rotterdam criteria are commonly used for diagnosis, which require at least two of the following three features:

1. Oligo- or anovulation (irregular menstrual cycles)
2. Clinical and/or biochemical signs of hyperandrogenism (e.g., hirsutism, acne, or high levels of androgens in the blood)
3. Polycystic ovaries on ultrasound examination (presence of 12 or more follicles measuring 2-9 mm in diameter, or increased ovarian volume >10 mL)

The exact cause of PCOS remains unclear, but it is believed to involve a combination of genetic and environmental factors. Insulin resistance and obesity are common findings in women with PCOS, which can contribute to the development of metabolic complications such as type 2 diabetes, dyslipidemia, and cardiovascular disease.

Management of PCOS typically involves a multidisciplinary approach that includes lifestyle modifications (diet, exercise, weight loss), medications to regulate menstrual cycles and reduce hyperandrogenism (e.g., oral contraceptives, metformin, anti-androgens), and fertility treatments if desired. Regular monitoring of metabolic parameters and long-term follow-up are essential for optimal management and prevention of complications.

Anestrus is a term used in veterinary medicine to describe the period of sexual quiescence in female animals, during which they do not exhibit estrous cycles. This phase is characterized by low levels of reproductive hormones and is seen in some species as a part of their natural reproductive cycle, while in others it may indicate an abnormality or underlying health issue.

For example, in dogs, anestrus is the period between heat cycles when the reproductive system is relatively inactive. In contrast, in domestic cats, continuous estrous cycling is the norm, and they do not typically exhibit an anestrus phase.

In some cases, anestrus may be induced by factors such as poor nutrition, stress, or illness, and it can have negative consequences for an animal's reproductive health if it persists for too long. If an animal is experiencing prolonged anestrus or other reproductive issues, it is important to consult with a veterinarian for proper diagnosis and treatment.

The cervix is the lower, narrow part of the uterus that opens into the vagina. Cervical mucus is a clear or cloudy secretion produced by glands in the cervix. The amount and consistency of cervical mucus changes throughout a woman's menstrual cycle, influenced by hormonal fluctuations.

During the fertile window (approximately mid-cycle), estrogen levels rise, causing the cervical mucus to become more abundant, clear, and stretchy (often described as resembling raw egg whites). This "fertile" mucus facilitates the movement of sperm through the cervix and into the uterus, increasing the chances of fertilization.

As the menstrual cycle progresses and progesterone levels rise after ovulation, cervical mucus becomes thicker, cloudier, and less abundant, making it more difficult for sperm to penetrate. This change in cervical mucus helps prevent additional sperm from entering and fertilizing an already-fertilized egg.

Changes in cervical mucus can be used as a method of natural family planning or fertility awareness, with women checking their cervical mucus daily to identify their most fertile days. However, this method should be combined with other tracking methods for increased accuracy and reliability.

Testicular hormones, also known as androgens, are a type of sex hormone primarily produced in the testes of males. The most important and well-known androgen is testosterone, which plays a crucial role in the development of male reproductive system and secondary sexual characteristics. Testosterone is responsible for the growth and maintenance of male sex organs, such as the testes and prostate, and it also promotes the development of secondary sexual characteristics like facial hair, deep voice, and muscle mass.

Testicular hormones are produced and regulated by a feedback system involving the hypothalamus and pituitary gland in the brain. The hypothalamus produces gonadotropin-releasing hormone (GnRH), which stimulates the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH stimulates the testes to produce testosterone, while FSH works together with testosterone to promote sperm production.

In addition to their role in male sexual development and function, testicular hormones also have important effects on other bodily functions, such as bone density, muscle mass, red blood cell production, mood, and cognitive function.

Follicle-Stimulating Hormone (FSH) is a glycoprotein hormone secreted by the anterior pituitary gland. In humans, FSH plays a crucial role in the reproductive system. Specifically, in females, it stimulates the growth of ovarian follicles in the ovary and the production of estrogen. In males, FSH promotes the formation of sperm within the testes' seminiferous tubules. The human FSH is a heterodimer, consisting of two noncovalently associated subunits: α (alpha) and β (beta). The alpha subunit is common to several pituitary hormones, including thyroid-stimulating hormone (TSH), luteinizing hormone (LH), and human chorionic gonadotropin (hCG). In contrast, the beta subunit is unique to FSH and determines its biological specificity. The regulation of FSH secretion is primarily controlled by the hypothalamic-pituitary axis, involving complex feedback mechanisms with gonadal steroid hormones and inhibins.

Estrus synchronization is a veterinary medical procedure used in the management of domestic animals, such as cattle and sheep. It is a process of coordinating the estrous cycles of animals so that they can be bred at the same time or have their fertility treatments performed simultaneously. This is achieved through the use of various hormonal therapies, including progestins, prostaglandins, and gonadotropin-releasing hormones (GnRH).

The goal of estrus synchronization is to improve reproductive efficiency in animal production systems by ensuring that a larger number of animals become pregnant during a shorter breeding season. This can lead to more uniform calf or lamb crops, reduced labor and management costs, and increased profitability for farmers and ranchers.

Estrus synchronization is a complex process that requires careful planning and implementation, as well as ongoing monitoring and evaluation of the animals' reproductive performance. It is typically performed under the guidance of a veterinarian or animal reproduction specialist.

Theca cells are specialized cells that are part of the follicle where the egg matures in the ovary. They are located in the outer layer of the follicle and play an important role in producing hormones necessary for the growth and development of the follicle and the egg within it. Specifically, they produce androgens, such as testosterone, which are then converted into estrogens by another type of cells in the follicle called granulosa cells. These hormones help to thicken the lining of the uterus in preparation for a possible pregnancy. In some cases, theca cells can become overactive and produce too much testosterone, leading to conditions such as polycystic ovary syndrome (PCOS).

An ovarian cyst is a sac or pouch filled with fluid that forms on the ovary. Ovarian cysts are quite common in women during their childbearing years, and they often cause no symptoms. In most cases, ovarian cysts disappear without treatment over a few months. However, larger or persistent cysts may require medical intervention, including surgical removal.

There are various types of ovarian cysts, such as functional cysts (follicular and corpus luteum cysts), which develop during the menstrual cycle due to hormonal changes, and non-functional cysts (dermoid cysts, endometriomas, and cystadenomas), which can form due to different causes.

While many ovarian cysts are benign, some may have malignant potential or indicate an underlying medical condition like polycystic ovary syndrome (PCOS). Regular gynecological check-ups, including pelvic examinations and ultrasounds, can help detect and monitor ovarian cysts.

Callithrix is a genus of New World monkeys, also known as marmosets. They are small, active primates found in the forests of South and Central America. The term "Callithrix" itself is derived from the Greek words "kallis" meaning beautiful and "thrix" meaning hair, referring to their thick, vibrantly colored fur.

Marmosets in the genus Callithrix are characterized by their slender bodies, long, bushy tails, and specialized dental structures that allow them to gouge tree bark to extract sap and exudates, which form a significant part of their diet. They also consume fruits, insects, and small vertebrates.

Some well-known species in this genus include the common marmoset (Callithrix jacchus), the white-headed marmoset (Callithrix geoffroyi), and the buffy-tufted-ear marmoset (Callithrix aurita). Marmosets are popular subjects of research due to their small size, short gestation period, and ease of breeding in captivity.

Aromatase is a enzyme that belongs to the cytochrome P450 superfamily, and it is responsible for converting androgens into estrogens through a process called aromatization. This enzyme plays a crucial role in the steroid hormone biosynthesis pathway, particularly in females where it is primarily expressed in adipose tissue, ovaries, brain, and breast tissue.

Aromatase inhibitors are used as a treatment for estrogen receptor-positive breast cancer in postmenopausal women, as they work by blocking the activity of aromatase and reducing the levels of circulating estrogens in the body.

The pregnancy rate is a measure used in reproductive medicine to determine the frequency or efficiency of conception following certain treatments, interventions, or under specific conditions. It is typically defined as the number of pregnancies per 100 women exposed to the condition being studied over a specified period of time. A pregnancy is confirmed when a woman has a positive result on a pregnancy test or through the detection of a gestational sac on an ultrasound exam.

In clinical trials and research, the pregnancy rate helps healthcare professionals evaluate the effectiveness of various fertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), or ovulation induction medications. The pregnancy rate can also be used to assess the impact of lifestyle factors, environmental exposures, or medical conditions on fertility and conception.

It is important to note that pregnancy rates may vary depending on several factors, including age, the cause of infertility, the type and quality of treatment provided, and individual patient characteristics. Therefore, comparing pregnancy rates between different studies should be done cautiously, considering these potential confounding variables.

Equine Gonadotropins are glycoprotein hormones derived from the pituitary gland of horses. They consist of two subunits: a common alpha subunit and a unique beta subunit that determines the biological activity of each hormone. There are two main types of equine gonadotropins: Equine Follicle Stimulating Hormone (eFSH) and Equine Luteinizing Hormone (eLH).

eFSH plays a crucial role in the growth and development of ovarian follicles in females, while eLH stimulates ovulation and the production of sex steroids in both males and females. These hormones are often used in veterinary medicine to induce ovulation and improve fertility in horses, as well as in research to study the physiology and biochemistry of gonadotropins and reproduction. It's important to note that equine gonadotropins have limited application in human reproductive medicine due to potential immunogenic reactions and other safety concerns.

Triptorelin pamoate is a synthetic analogue of the natural hormone gonadotropin-releasing hormone (GnRH). It is used in the treatment of various conditions such as endometriosis, uterine fibroids, precocious puberty, and prostate cancer.

Triptorelin pamoate works by stimulating the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland, which in turn stimulate the production of sex hormones such as estrogen and testosterone. However, with continued use, it causes downregulation of the pituitary gland, leading to a decrease in the production of FSH and LH, and therefore a reduction in the levels of sex hormones.

The pamoate salt is used to slow down the release of triptorelin, allowing for longer-acting formulations that can be administered monthly or quarterly. The medication is usually given as an injection into a muscle (intramuscularly).

Dinoprost is a synthetic form of prostaglandin F2α, which is a naturally occurring hormone-like substance in the body. It is used in veterinary medicine as a uterotonic agent to induce labor and abortion in various animals such as cows and pigs. In human medicine, it may be used off-label for similar purposes, but its use must be under the close supervision of a healthcare provider due to potential side effects and risks.

It is important to note that Dinoprost is not approved by the FDA for use in humans, and its availability may vary depending on the country or region. Always consult with a licensed healthcare professional before using any medication, including Dinoprost.

Sex Hormone-Binding Globulin (SHBG) is a protein produced mainly in the liver that plays a crucial role in regulating the active forms of the sex hormones, testosterone and estradiol, in the body. SHBG binds to these hormones in the bloodstream, creating a reservoir of bound hormones. Only the unbound (or "free") fraction of testosterone and estradiol is considered biologically active and can easily enter cells to exert its effects.

By binding to sex hormones, SHBG helps control their availability and transport in the body. Factors such as age, sex, infection with certain viruses (like hepatitis or HIV), liver disease, obesity, and various medications can influence SHBG levels and, consequently, impact the amount of free testosterone and estradiol in circulation.

SHBG is an essential factor in maintaining hormonal balance and has implications for several physiological processes, including sexual development, reproduction, bone health, muscle mass, and overall well-being. Abnormal SHBG levels can contribute to various medical conditions, such as hypogonadism (low testosterone levels), polycystic ovary syndrome (PCOS), and certain types of cancer.

Prolactin is a hormone produced by the pituitary gland, a small gland located at the base of the brain. Its primary function is to stimulate milk production in women after childbirth, a process known as lactation. However, prolactin also plays other roles in the body, including regulating immune responses, metabolism, and behavior. In men, prolactin helps maintain the sexual glands and contributes to paternal behaviors.

Prolactin levels are usually low in both men and non-pregnant women but increase significantly during pregnancy and after childbirth. Various factors can affect prolactin levels, including stress, sleep, exercise, and certain medications. High prolactin levels can lead to medical conditions such as amenorrhea (absence of menstruation), galactorrhea (spontaneous milk production not related to childbirth), infertility, and reduced sexual desire in both men and women.

Oral contraceptives, also known as "birth control pills," are medications taken by mouth to prevent pregnancy. They contain synthetic hormones that mimic the effects of natural hormones estrogen and progesterone in a woman's body, thereby preventing ovulation, fertilization, or implantation of a fertilized egg in the uterus.

There are two main types of oral contraceptives: combined pills, which contain both estrogen and progestin, and mini-pills, which contain only progestin. Combined pills work by preventing ovulation, thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant. Mini-pills work mainly by thickening cervical mucus and changing the lining of the uterus.

Oral contraceptives are highly effective when used correctly, but they do not protect against sexually transmitted infections (STIs). It is important to use them consistently and as directed by a healthcare provider. Side effects may include nausea, breast tenderness, headaches, mood changes, and irregular menstrual bleeding. In rare cases, oral contraceptives may increase the risk of serious health problems such as blood clots, stroke, or liver tumors. However, for most women, the benefits of using oral contraceptives outweigh the risks.

Hydrocortisone is a synthetic glucocorticoid, which is a class of steroid hormones. It is identical to the naturally occurring cortisol, a hormone produced by the adrenal gland that helps regulate metabolism and helps your body respond to stress. Hydrocortisone has anti-inflammatory effects and is used to treat various inflammatory conditions such as allergies, skin disorders, and autoimmune diseases. It works by suppressing the immune system's response to reduce swelling, redness, itching, and other symptoms caused by inflammation.

Hydrocortisone is available in different forms, including oral tablets, topical creams, lotions, gels, and ointments, as well as injectable solutions. The specific use and dosage depend on the condition being treated and the individual patient's medical history and current health status.

As with any medication, hydrocortisone can have side effects, especially when used in high doses or for extended periods. Common side effects include increased appetite, weight gain, mood changes, insomnia, and skin thinning. Long-term use of hydrocortisone may also increase the risk of developing osteoporosis, diabetes, cataracts, and other health problems. Therefore, it is essential to follow your healthcare provider's instructions carefully when using this medication.

The vagina is the canal that joins the cervix (the lower part of the uterus) to the outside of the body. It also is known as the birth canal because babies pass through it during childbirth. The vagina is where sexual intercourse occurs and where menstrual blood exits the body. It has a flexible wall that can expand and retract. During sexual arousal, the vaginal walls swell with blood to become more elastic in order to accommodate penetration.

It's important to note that sometimes people use the term "vagina" to refer to the entire female genital area, including the external structures like the labia and clitoris. But technically, these are considered part of the vulva, not the vagina.

I believe you are looking for a medical or scientific term that is related to elephants, as there is no medical definition for the word "elephants" itself. Elephants are large mammals of the family Elephantidae and the order Proboscidea. They are native to Africa and Asia and are known for their long trunks, large ears, and tusks.

One possible connection between elephants and medicine is the use of elephant ivory in medical equipment. In the past, elephant ivory was used to make a variety of medical instruments, such as dental tools and surgical instruments. However, due to concerns about animal welfare and the illegal trade in elephant ivory, the use of elephant ivory in medical equipment has become increasingly rare.

Another possible connection between elephants and medicine is the study of their social behavior and communication, which may provide insights into human social behavior and mental health. For example, research has shown that elephants have complex social structures and exhibit behaviors such as empathy, cooperation, and mourning, which are also important aspects of human social and emotional functioning.

Overall, while there is no specific medical definition for "elephants," these fascinating animals have contributed to our understanding of biology, medicine, and human behavior in various ways.

Reference values, also known as reference ranges or reference intervals, are the set of values that are considered normal or typical for a particular population or group of people. These values are often used in laboratory tests to help interpret test results and determine whether a patient's value falls within the expected range.

The process of establishing reference values typically involves measuring a particular biomarker or parameter in a large, healthy population and then calculating the mean and standard deviation of the measurements. Based on these statistics, a range is established that includes a certain percentage of the population (often 95%) and excludes extreme outliers.

It's important to note that reference values can vary depending on factors such as age, sex, race, and other demographic characteristics. Therefore, it's essential to use reference values that are specific to the relevant population when interpreting laboratory test results. Additionally, reference values may change over time due to advances in measurement technology or changes in the population being studied.

Hydroxyprogesterone is a synthetic form of the natural hormone progesterone, which is produced by the body during pregnancy to support the growth and development of the fetus. Hydroxyprogesterone is used in medical treatments to help prevent preterm birth in certain high-risk pregnancies.

There are several different forms of hydroxyprogesterone that have been developed for use as medications, including:

1. Hydroxyprogesterone caproate (HPC): This is a synthetic form of progesterone that is given as an injection once a week to help prevent preterm birth in women who have previously given birth prematurely. It works by helping to thicken the lining of the uterus and prevent contractions.
2. 17-Hydroxyprogesterone: This is a natural hormone that is produced by the body during pregnancy, but it can also be synthesized in a laboratory for use as a medication. It has been studied for its potential to help prevent preterm birth, although it is not currently approved for this use by the U.S. Food and Drug Administration (FDA).
3. 21-Hydroxyprogesterone: This is another natural hormone that is produced by the body during pregnancy, but it can also be synthesized in a laboratory for use as a medication. It has been studied for its potential to help prevent preterm birth and for its ability to reduce the risk of certain complications in women with a history of premature birth.

It's important to note that hydroxyprogesterone should only be used under the supervision of a healthcare provider, as it can have side effects and may not be appropriate for all women. If you are pregnant or planning to become pregnant and have concerns about preterm birth, it's important to discuss your options with your healthcare provider.

Oral hormonal contraceptives, also known as "birth control pills," are a type of medication that contains synthetic hormones (estrogen and/or progestin) that are taken by mouth to prevent pregnancy. They work by preventing ovulation (the release of an egg from the ovaries), thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant.

There are several different types of oral hormonal contraceptives, including combined pills that contain both estrogen and progestin, and mini-pills that only contain progestin. These medications are usually taken daily for 21 days, followed by a seven-day break during which menstruation occurs. Some newer formulations may be taken continuously with no break.

It's important to note that while oral hormonal contraceptives are highly effective at preventing pregnancy when used correctly, they do not protect against sexually transmitted infections (STIs). Therefore, it is still important to use barrier methods of protection, such as condoms, during sexual activity to reduce the risk of STIs.

As with any medication, oral hormonal contraceptives can have side effects and may not be suitable for everyone. It's important to discuss any medical conditions, allergies, or medications you are taking with your healthcare provider before starting to take oral hormonal contraceptives.

Hirsutism is a medical condition characterized by excessive hair growth in women in areas where hair growth is typically androgen-dependent, such as the face, chest, lower abdomen, and inner thighs. This hair growth is often thick, dark, and coarse, resembling male-pattern hair growth. Hirsutism can be caused by various factors, including hormonal imbalances, certain medications, and genetic conditions. It's essential to consult a healthcare professional if you experience excessive or unwanted hair growth to determine the underlying cause and develop an appropriate treatment plan.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Progestins are a class of steroid hormones that are similar to progesterone, a natural hormone produced by the ovaries during the menstrual cycle and pregnancy. They are often used in hormonal contraceptives, such as birth control pills, shots, and implants, to prevent ovulation and thicken the cervical mucus, making it more difficult for sperm to reach the egg. Progestins are also used in menopausal hormone therapy to alleviate symptoms of menopause, such as hot flashes and vaginal dryness. Additionally, progestins may be used to treat endometriosis, uterine fibroids, and breast cancer. Different types of progestins have varying properties and may be more suitable for certain indications or have different side effect profiles.

Embryo transfer is a medical procedure that involves the transfer of an embryo, which is typically created through in vitro fertilization (IVF), into the uterus of a woman with the aim of establishing a pregnancy. The embryo may be created using the intended parent's own sperm and eggs or those from donors. After fertilization and early cell division, the resulting embryo is transferred into the uterus of the recipient mother through a thin catheter that is inserted through the cervix. This procedure is typically performed under ultrasound guidance to ensure proper placement of the embryo. Embryo transfer is a key step in assisted reproductive technology (ART) and is often used as a treatment for infertility.

The sex ratio is not a medical term per se, but it is a term used in demography and population health. The sex ratio is the ratio of males to females in a given population. It is typically expressed as the number of males for every 100 females. A sex ratio of 100 would indicate an equal number of males and females.

In the context of human populations, the sex ratio at birth is usually around 103-107 males per 100 females, reflecting a slightly higher likelihood of male births. However, due to biological factors such as higher male mortality rates in infancy and childhood, as well as social and behavioral factors, the sex ratio tends to equalize over time and can even shift in favor of women in older age groups.

It's worth noting that significant deviations from the expected sex ratio at birth or in a population can indicate underlying health issues or societal problems. For example, skewed sex ratios may be associated with gender discrimination, selective abortion of female fetuses, or exposure to environmental toxins that affect male reproductive health.

"Swine" is a common term used to refer to even-toed ungulates of the family Suidae, including domestic pigs and wild boars. However, in a medical context, "swine" often appears in the phrase "swine flu," which is a strain of influenza virus that typically infects pigs but can also cause illness in humans. The 2009 H1N1 pandemic was caused by a new strain of swine-origin influenza A virus, which was commonly referred to as "swine flu." It's important to note that this virus is not transmitted through eating cooked pork products; it spreads from person to person, mainly through respiratory droplets produced when an infected person coughs or sneezes.

Dehydroepiandrosterone sulfate (DHEA-S) is a steroid hormone that is produced by the adrenal glands. It is a modified form of dehydroepiandrosterone (DHEA), which is converted to DHEA-S in the body for storage and later conversion back to DHEA or other steroid hormones, such as testosterone and estrogen. DHEA-S is often measured in the blood as a marker of adrenal function. It is also available as a dietary supplement, although its effectiveness for any medical purpose is not well established.

Analysis of Variance (ANOVA) is a statistical technique used to compare the means of two or more groups and determine whether there are any significant differences between them. It is a way to analyze the variance in a dataset to determine whether the variability between groups is greater than the variability within groups, which can indicate that the groups are significantly different from one another.

ANOVA is based on the concept of partitioning the total variance in a dataset into two components: variance due to differences between group means (also known as "between-group variance") and variance due to differences within each group (also known as "within-group variance"). By comparing these two sources of variance, ANOVA can help researchers determine whether any observed differences between groups are statistically significant, or whether they could have occurred by chance.

ANOVA is a widely used technique in many areas of research, including biology, psychology, engineering, and business. It is often used to compare the means of two or more experimental groups, such as a treatment group and a control group, to determine whether the treatment had a significant effect. ANOVA can also be used to compare the means of different populations or subgroups within a population, to identify any differences that may exist between them.

In a medical context, feedback refers to the information or data about the results of a process, procedure, or treatment that is used to evaluate and improve its effectiveness. This can include both quantitative data (such as vital signs or laboratory test results) and qualitative data (such as patient-reported symptoms or satisfaction). Feedback can come from various sources, including patients, healthcare providers, medical equipment, and electronic health records. It is an essential component of quality improvement efforts, allowing healthcare professionals to make informed decisions about changes to care processes and treatments to improve patient outcomes.

The anterior pituitary, also known as the adenohypophysis, is the front portion of the pituitary gland. It is responsible for producing and secreting several important hormones that regulate various bodily functions. These hormones include:

* Growth hormone (GH), which stimulates growth and cell reproduction in bones and other tissues.
* Thyroid-stimulating hormone (TSH), which regulates the production of thyroid hormones by the thyroid gland.
* Adrenocorticotropic hormone (ACTH), which stimulates the adrenal glands to produce cortisol and other steroid hormones.
* Follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which regulate reproductive function in both males and females by controlling the development and release of eggs or sperm.
* Prolactin, which stimulates milk production in pregnant and nursing women.
* Melanocyte-stimulating hormone (MSH), which regulates skin pigmentation and appetite.

The anterior pituitary gland is controlled by the hypothalamus, a small region of the brain located just above it. The hypothalamus produces releasing and inhibiting hormones that regulate the secretion of hormones from the anterior pituitary. These hormones are released into a network of blood vessels called the portal system, which carries them directly to the anterior pituitary gland.

Damage or disease of the anterior pituitary can lead to hormonal imbalances and various medical conditions, such as growth disorders, thyroid dysfunction, adrenal insufficiency, reproductive problems, and diabetes insipidus.

Assisted reproductive techniques (ART) are medical procedures that involve the handling of human sperm and ova to establish a pregnancy. These techniques are used when other methods of achieving pregnancy have failed or are not available. Examples of ART include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), gamete intrafallopian transfer (GIFT), and zygote intrafallopian transfer (ZIFT). These procedures may be used to treat infertility, prevent genetic disorders, or to help same-sex couples or single people have children. It is important to note that the use of ART can involve significant physical, emotional, and financial costs, and it may not always result in a successful pregnancy.

Steroids, also known as corticosteroids, are a type of hormone that the adrenal gland produces in your body. They have many functions, such as controlling the balance of salt and water in your body and helping to reduce inflammation. Steroids can also be synthetically produced and used as medications to treat a variety of conditions, including allergies, asthma, skin conditions, and autoimmune disorders.

Steroid medications are available in various forms, such as oral pills, injections, creams, and inhalers. They work by mimicking the effects of natural hormones produced by your body, reducing inflammation and suppressing the immune system's response to prevent or reduce symptoms. However, long-term use of steroids can have significant side effects, including weight gain, high blood pressure, osteoporosis, and increased risk of infections.

It is important to note that anabolic steroids are a different class of drugs that are sometimes abused for their muscle-building properties. These steroids are synthetic versions of the male hormone testosterone and can have serious health consequences when taken in large doses or without medical supervision.

"Cattle" is a term used in the agricultural and veterinary fields to refer to domesticated animals of the genus *Bos*, primarily *Bos taurus* (European cattle) and *Bos indicus* (Zebu). These animals are often raised for meat, milk, leather, and labor. They are also known as bovines or cows (for females), bulls (intact males), and steers/bullocks (castrated males). However, in a strict medical definition, "cattle" does not apply to humans or other animals.

"Macaca mulatta" is the scientific name for the Rhesus macaque, a species of monkey that is native to South, Central, and Southeast Asia. They are often used in biomedical research due to their genetic similarity to humans.

In the context of medicine, "periodicity" refers to the occurrence of events or phenomena at regular intervals or cycles. This term is often used in reference to recurring symptoms or diseases that have a pattern of appearing and disappearing over time. For example, some medical conditions like menstrual cycles, sleep-wake disorders, and certain infectious diseases exhibit periodicity. It's important to note that the duration and frequency of these cycles can vary depending on the specific condition or individual.

"Animal pregnancy" is not a term that is typically used in medical definitions. However, in biological terms, animal pregnancy refers to the condition where a fertilized egg (or eggs) implants and develops inside the reproductive tract of a female animal, leading to the birth of offspring (live young).

The specific details of animal pregnancy can vary widely between different species, with some animals exhibiting phenomena such as placental development, gestation periods, and hormonal changes that are similar to human pregnancy, while others may have very different reproductive strategies.

It's worth noting that the study of animal pregnancy and reproduction is an important area of biological research, as it can provide insights into fundamental mechanisms of embryonic development, genetics, and evolution.

The follicular phase, also known as the preovulatory phase or proliferative phase, is the phase of the estrous cycle (or, in ... The duration of the follicular phase can differ depending on the length of the menstrual cycle, while the luteal phase is ... Throughout the entire follicular phase, rising estrogen levels in the blood stimulates growth of the endometrium and myometrium ... Inhibin B will eventually blunt the secretion of FSH toward the end of the follicular phase. Inhibin B levels will be highest ...
... ends when you ovulate and happens to be the longest phase of a ladys monthly cycle. Its also a time of month when you might ... If youre wondering what is the follicular phase, here are the basics: It starts on the first day of your period, ... How do I know when Im in the follicular phase?. Given that the follicular phase is the time of the month when you have tons of ... What is the follicular phase?. As previously mentioned, the follicular phase begins on the first day of your period, lasts ...
Help for short follicular phase/luteal phase. Blog › Forums › Womens Health › Help for short follicular phase/luteal phase ... From what I know, a short follicular phase can be caused by increasing age, stress, alcohol, as well as high estrogen, so it ... 2.) My cycle patterns clearly show that this is not "enough", i.e., the opposite of PCOS, which has long follicular phases from ... Your luteal phase actually ends when you start the true bleeding, not the spotting, so your luteal phase is longer than 9 days ...
Access a live Likelihood of Approval and Phase Transition Success Rate Model - Maplirpacept in Follicular Lymphoma dashboard ... Likelihood of Approval and Phase Transition Success Rate Model - Maplirpacept in Follicular Lymphoma. Powered by ... What is Phase Transition Success Rate (PTSR)?. The probability of a drugs advancement to the next stage of clinical ... How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report ...
Youll burn fat and gain lean muscle more easily in the follicular phase if you workout in a way that supports cycle syncing. ... Working out in your follicular phase. In the follicular phase of your cycle, youll burn fat and gain lean muscle more easily. ... you get stronger and gain more muscle compared to the luteal phase. ⁠⁠. ⁠⁠. Your BMR decreases during the follicular phase (it ... PrevPreviousEP83: How to best fuel your workouts in the follicular and luteal phases [cycle syncing] ...
We conclude that manipulation of the follicular phase by shortening the period of E exposure to 7 days, does not compromise ... Manipulation of the follicular phase uterine epithelium in women undergoing infertility treatment, has not generally shown ... From: Manipulation of the follicular phase: Uterodomes and pregnancy - is there a correlation? ...
two distinct phases. . Follicular phase. During the last few days. of a period, the pituitary gland stimulates the production ... Luteal phase. After ovulation, the luteal phase begins. If sperm fertilizes the egg, it will travel down the fallopian tube and ... When menstruation begins, it marks the beginning of a new follicular phase, and the cycle begins again. ... In this article, learn more about what menstruation is, when it starts, the phases of the menstrual cycle, and how to manage ...
Follicular phase. The first half of the cycle is called the follicular phase. During this phase, estrogen levels are higher ... and consists of two main phases: the follicular phase and the luteal phase. ... Luteal phase. The second phase of the cycle, after ovulation, is the luteal phase. In this part of the cycle, progesterone ... Females in the follicular phase rated the importance of kissing in the initial stages of a relationship more highly than ...
... well be taking a look at the Follicular Phase. Known as our Inner Spring our Follicular Phase technically starts on Day 1 of ... our period - but most people dont get those lovely follicular feels until their period starts to end. Here well break down ... The Science Of Your Cycle - Follicular Phase. So, what exactly is the follicular phase and whats going on with our hormones ... Self-Care During Your Follicular Phase. Whilst you might feel happy and full of energy during your follicular phase, that ...
The menstrual cycle can be divided into 3 physiologic phases: follicular, ovulatory, and luteal. Each phase has a distinct ... Follicular phase. In physiologic terms, the first day of menses is considered the first day of the menstrual cycle. The ... During the late follicular phase, estrogen has a positive influence on LH secretion, instead of suppressing pituitary LH ... GnRH interacts with the anterior pituitary gland to stimulate release of FSH in the follicular phase. FSH is secreted into the ...
... were diving deep into each phase of the Menstrual Cycle. With each phase, Ill cover how to sync your life with your cycle to ... Whats going on during this phase:. The Follicular Phase technically overlaps with the Menstrual Phase, starting with the first ... This week Im talking all about the Follicular Phase. If you missed last week, click here to read all about the Menstrual Phase ... This is gearing your body up for the ovulatory phase. Head back next week to learn about the next phase: the Ovulatory Phase! ...
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience ...
Use boolean operators (AND, OR, NOT) to search by multiple keywords. e.g. Keyword 1 AND Keyword 2. ...
The follicular phase corresponds to the Waxing Moon and the season of Spring, the beginning of a new cycle of growth. Seeds ... The conclusion of our menstrual flow marks the beginning of the follicular or pre-ovulatory phase. During this time t. he ... Please keep in mind that each body is unique and not all cycle phases will align with the specific Moon and Earth phases that ... Described throughout this series are the four phases of the menstrual cycle, the hormones involved in each phase, the related ...
Phase two: Follicular. The follicular phase technically occurs during both the menstruation and ovulation phases. It begins on ... Remember that egg we talked about in the follicular phase? Well, now is its time to shine. Estrogen levels are at their peak, ... One of the signs that you are in your follicular phase is an increased body temperature and a higher sex drive. ... Phase four: Luteal. After ovulation comes the luteal phase. It typically lasts around 10-16 days and is responsible for the ...
Curious about the follicular phase of the menstrual cycle? Click here at Always as we decode the meaning of the follicular ...
Luteal Phase Stimulation. The menstrual cycle is divided into the follicular phase followed by ovulation… ... The menstrual cycle is divided into the follicular phase followed by ovulation and the luteal phase. The stimulation of ovaries ... ICSIivf drugsivf failureivf researchluiluteal phaseluteal phase defectmale infertilitymetforminmorulamyo-inositolnewsnutrition ... female infertilityfertilityfertility consulationfertility drugsfertility treatmentfertility trendsfolic acidfollicular phasefsh ...
... beigenemedical.info/3258/zanubrutinib-in-follicular-lymphoma-the-phase-2-rosewood-trial/ ... Slide kit describing a treatment option for relapsed/refractory (R/R) follicular lymphoma (FL) with a BTKi and an anti-CD20 ...
While you may still experience some PMS symptoms in this phase too, the more likely symptoms of the follicular phase tend to ... So youre in the follicular phase? You lucky thing! ... Weve reached the follicular phase in our series on the phases ... What is the follicular phase?. Lets start with a quick recap of the menstrual cycle phases. In the ovulation phase, an egg is ... What if my follicular phase is shorter than it should be?. On the flip side, a shorter follicular phase can affect your chances ...
The follicular phase overlaps with the menstrual phase and begins on the first day of your period. ... There are four menstrual cycle phases: menstrual, follicular, ovulation, and luteal.. *Fertility tracking can serve as a useful ... This phase starts when the hypothalamus, a region of the brain responsible for hormone release, sends a signal to the pituitary ... This process is known as the luteal phase and it lasts about 11 to 17 days, with an average length of 14 days. Then, your ...
Protected: Full Circle Woman: The Follicular Phase This content is password protected. To view it please enter your password ...
One way to practice hormonal maintenance is by eating in tune with the four main phases of your menstrual cycle: heres exactly ... Follicular Phase During the follicular phase, which follows menstruation and precedes ovulation, estrogen and testosterone ... Luteal phase The next phase of your cycle is called the luteal phase: It follows ovulation and precedes your next period. ... which is rising during the follicular phase) and help estrogen and testosterone peak appropriately. ...
This tea set has been designed to support each phase of the menstrual cycle, balance hormones, regulate irregular cycles and ... Waxing Moon Tea , Tea for the Follicular Phase of the Menstrual Cycle. Size. Large Glass Apothecary Jars. Small Glass ... Waxing Moon Tea: Herbs for the follicular phase of the menstrual cycle. Blended to support hormone balance including healthy ... Home › Waxing Moon Tea , Tea for the Follicular Phase of the Menstrual Cycle ...
The premature rise of progesterone during the late follicular phase in stimulated IVF cycles is a frequent event, and emerging ... The effect of elevated peripheral progesterone levels in the late follicular phase seems to be on the endometrium and the ... Effect of progesterone elevation in follicular phase of IVF-cycles on the endometrial receptivity. ...
Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance). ... Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma : CALGB 50901 (Alliance). In: ... Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance). / ... Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance). ...
It occurs during, and is synchronous with, the follicular phase.. Luteal Phase: the phase of the cycle beginning at the time of ... The luteal phase. It is during the follicular phase that an egg begins to develop and mature inside a fluid-filled sac within ... Follicular Phase: the phase of the menstrual cycle beginning on day one and continuing until the time of ovulation. ... FSH continues to control the development of the egg(s) and follicle(s) throughout the follicular phase. When the one egg ...
Phase II study of bendamustine/rituximab with bortezomib induction or lenalidomide continuation in untreated follicular ... Dive into the research topics of A three-arm randomized Phase II study of bendamustine/rituximab with bortezomib induction or ... T1 - A three-arm randomized Phase II study of bendamustine/rituximab with bortezomib induction or lenalidomide continuation in ... A three-arm randomized Phase II study of bendamustine/rituximab with bortezomib induction or lenalidomide continuation in ...
Elevation of Plasma FSH with a Low Level of FSH-P During the Early to Mid Follicular Phase Blocks the Loss of Greater Numbers ... Large preovulatory follicles were slower to develop in RS gilts and it was not until late in the follicular phase that RS gilts ... during the early to mid follicular phase of the estrous cycle will prevent the loss of medium follicles and reverse the pattern ... during the late luteal and early follicular phases of the estrous cycle (days 12 to 14). The elevated concentrations of FSH in ...
Bovine Uterine Fluid from Late Follicular Phase of the Estrous Cycle (Pre-Ovulation). Frozen product. Antibiotic-free. ... Bovine uterine fluid (BUF) collected from uterus of cows at the late follicular phase of the estrous cycle (just before ...
Phase II study of bendamustine/rituximab with bortezomib induction or lenalidomide continuation in untreated follicular ... Dive into the research topics of A three-arm randomized Phase II study of bendamustine/rituximab with bortezomib induction or ... T1 - A three-arm randomized Phase II study of bendamustine/rituximab with bortezomib induction or lenalidomide continuation in ... A three-arm randomized Phase II study of bendamustine/rituximab with bortezomib induction or lenalidomide continuation in ...
  • Maplirpacept (TTI-622) is under development for the treatment of relapsed and refractory multiple myeloma, acute myelocytic leukemia, relapsed and refractory lymphoma, indolent non-Hodgkin's lymphoma, classic Hodgkin's lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, peripheral T-cell lymphomas (PTCL) and cutaneous T-cell lymphoma, solid tumors and platinum-resistant epithelial ovarian cancer (EOC), fallopian tube carcinoma (FTC) or primary peritoneal carcinomas (PPC). (globaldata.com)
  • Slide kit describing a treatment option for relapsed/refractory (R/R) follicular lymphoma (FL) with a BTKi and an anti-CD20 monoclonal antibody. (beigenemedical.info)
  • Rituximab monotherapy has proven efficacy in treatment-naïve, asymptomatic advanced-stage follicular lymphoma (FL). (johnshopkins.edu)
  • Purpose: We sought to improve upon frontline bendamustine/ rituximab (BR) induction therapy followed by rituximab maintenance in untreated high-risk follicular lymphoma (FL). (wustl.edu)
  • Together, they put half of the patients with relapsed follicular lymphoma into complete remission in a phase II clinical trial. (sciencedaily.com)
  • Such mild effects are particularly important for follicular lymphoma patients, who are diagnosed with the disease at a median age of 60. (sciencedaily.com)
  • Research showed PD1 is highly expressed on T cells in the bloodstream and tumors of follicular lymphoma patients and also is associated with impaired T cell function. (sciencedaily.com)
  • Follicular lymphoma is a cancer of B cells. (sciencedaily.com)
  • The next-generation inhibitor of Bruton's tyrosine kinase (BTK) may be effective in mantle cell lymphoma for patients previously treated with an older BTK inhibitor, according to results from the phase I/II BRUIN trial. (ascopost.com)
  • As reported in The New England Journal of Medicine by Frederick L. Locke, MD, and colleagues, the phase III ZUMA-7 trial of patients with large B-cell lymphoma has shown improved event-free survival with second-line axicabtagene ciloleucel vs chemoimmunotherapy with high-dose chemotherapy and. (ascopost.com)
  • Idiotype vaccine therapy (Biovax ID) in follicular lymphoma in first complete remission: phase III clinical trial results. (nature.com)
  • Valemetostat is under clinical development by Daiichi Sankyo and currently in Phase II for Follicular Lymphoma. (pharmaceutical-technology.com)
  • According to GlobalData, Phase II drugs for Follicular Lymphoma have a 45% phase transition success rate (PTSR) indication benchmark for progressing into Phase III. (pharmaceutical-technology.com)
  • Follicular lymphoma, low-power view. (medscape.com)
  • Follicular lymphoma is a type of non-Hodgkin lymphoma that most commonly presents as a painless, slowly progressive adenopathy. (medscape.com)
  • Because the chromosomal t(14;18) translocation is found in the majority of patients with follicular lymphoma, bone marrow aspiration and chromosome analysis can also help establish the diagnosis. (medscape.com)
  • Most patients with follicular lymphoma present at an advanced stage, and most patients have bone marrow involvement at diagnosis. (medscape.com)
  • Clinically, grade 3B follicular lymphoma is treated like diffuse large B-cell lymphoma . (medscape.com)
  • Multiagent chemotherapy in combination with rituximab is the most common first-line treatment strategy for follicular lymphoma. (medscape.com)
  • Women who are hoping to conceive should know that a lengthy follicular phase has no impact on fertility, whereas an abnormally short follicular phase can indicate hormone levels that are less conducive to conception. (purewow.com)
  • From what I know, a short follicular phase can be caused by increasing age, stress, alcohol, as well as high estrogen, so it could not be a low hormone problem (overall). (180degreehealth.com)
  • A short follicular phase can mean your FSH levels will rise as normal, but your LH stays low, causing the follicle to mature too quickly for the egg. (yoppie.com)
  • In the ovulation phase, an egg is released, and during the luteal phase, the uterine lining thickens to support the egg's growth. (yoppie.com)
  • The truth is, some people do have a long follicular phase if it takes longer for a dominant follicle to mature, and therefore the ovulation phase can be longer too. (yoppie.com)
  • As FSH increases during the early portion of the follicular phase, it meshes with granulosa cells to stimulate the aromatization of androgens into estradiol. (medscape.com)
  • Make sure that you have your progesterone and estradiol checked at seven days after ovulation to check for luteal phase defect which is common in women who exercise regularly. (bellaonline.com)
  • The chemical name for ethyndiol diacetate is 19-nor-17alpha-pregn-4-en-20-yne-3beta,17-diol diacetate, and for ethinyl estradiol it is 19-nor- 17alpha-pregna-1,3,5 (10)-trien-20-yne-3,17-diol. (rxlist.com)
  • 2.) My cycle patterns clearly show that this is not "enough", i.e., the opposite of PCOS, which has long follicular phases from excess of everything. (180degreehealth.com)
  • The follicular phase, also known as the preovulatory phase or proliferative phase, is the phase of the estrous cycle (or, in primates for example, the menstrual cycle) during which follicles in the ovary mature from primary follicle to a fully mature graafian follicle. (wikipedia.org)
  • These follicles take months to grow and develop, but in our follicular phase, there will usually be one follicle that becomes dominant. (myoovi.us)
  • During this phase, Follicle-Stimulating Hormone (FSH) is made in the brain, triggering eggs in the ovary to develop and mature. (drdanielledesroche.com)
  • The follicular phase basically makes up the first half of your cycle, and it starts when the hypothalamus (kind of like the hormone command centre) sends a signal to the pituitary gland in your brain telling it to release something called FSH (follicle-stimulating hormone). (yoppie.com)
  • This phase starts when the hypothalamus, a region of the brain responsible for hormone release, sends a signal to the pituitary gland to release follicle-stimulating hormone (FSH). (greatist.com)
  • The luteal phase follows ovulation and involves the transformation of the ruptured follicle into the corpus luteum, which produces progesterone. (healthifyme.com)
  • Because functional follicles, which are stimulated by follicle-stimulating hormone (FSH) during the first part of the menstrual cycle, have declined in number, less recruitment of oocytes occurs, and the follicular phase shortens accordingly. (medscape.com)
  • The follicular theory postulates that the dental follicle is capable of inducing, guiding and coordinating the bone resorption above the crown of a teeth undergoing formation and bone apposition below this same crown, which enables that during the intraosseous eruptive phase of the tooth eruption process the formation of a eruptive path occur and the tooth undergoing formation be passively conducted through this path 6,15 . (bvsalud.org)
  • The menstrual cycle can be divided into 3 physiologic phases: follicular, ovulatory, and luteal. (medscape.com)
  • The conclusion of our menstrual flow marks the beginning of the follicular or pre-ovulatory phase. (thenectarnest.ca)
  • These chemical reactions all contribute to your cycle, but to simplify, it happens in four general phases: menstruation (your period), follicular, ovulatory and luteal. (heraldextra.com)
  • These alterations in FSH may act in concert with disrupted LH pulsatility as a primary and proximate factor in the high frequency of luteal phase and ovulatory disturbances in regularly menstruating, exercising women. (bellaonline.com)
  • It also causes endometrial cells to produce receptors for progesterone, which helps prime the endometrium to respond to rising levels of progesterone during the late proliferative phase and throughout the luteal phase. (wikipedia.org)
  • The premature rise of progesterone during the late follicular phase in stimulated IVF cycles is a frequent event, and emerging evidence shows that premature progesterone rise does negatively affect the outcome of assisted reproductive techniques. (artfertilityclinics.com)
  • Throughout the entire follicular phase, rising estrogen levels in the blood stimulates growth of the endometrium and myometrium of the uterus. (wikipedia.org)
  • During this phase, estrogen levels are higher than progesterone levels. (medicalnewstoday.com)
  • During the Follicular Phase, you want to focus on foods that support estrogen levels, especially if you deal with PMS or painful and heavy periods. (drdanielledesroche.com)
  • Nearing the end of the menstrual phase, estrogen levels slowly begin to rise and there is a sense of awakening , we may feel more drawn to leave our menstrual 'cave' so to speak and return back into the world. (thenectarnest.ca)
  • For the sake of cycle syncing though, we will consider the start of the Follicular Phase as the day you stop bleeding going up until ovulation. (drdanielledesroche.com)
  • Cycle syncing is aligning the way you eat and exercise to match your menstrual cycle phase for better hormone balance. (pinterest.ch)
  • In this article, learn more about what menstruation is, when it starts, the phases of the menstrual cycle, and how to manage them. (medicalnewstoday.com)
  • When menstruation begins, it marks the beginning of a new follicular phase, and the cycle begins again. (medicalnewstoday.com)
  • This article will help guide your activity during each phase that will optimize the way you manage menstruation and leave you feeling more in tune with your body. (heraldextra.com)
  • The follicular phase technically occurs during both the menstruation and ovulation phases. (heraldextra.com)
  • During the follicular phase, which follows menstruation and precedes ovulation, estrogen and testosterone start to rise and peak. (mindbodygreen.com)
  • Though it's possible to get pregnant during any phase of menstruation, it's most likely during ovulation (this is also why you might be feeling especially horny ! (mindbodygreen.com)
  • As previously mentioned, the follicular phase begins on the first day of your period, lasts until ovulation day, and accounts for the first half of the menstrual cycle. (purewow.com)
  • A surprisingly high number of women who run regularly experience cessation of ovulation (anovulation) and luteal phase defect (LPD) where the second half of the menstrual cycle is both shortened and deficient in progesterone which is critical for maintaining pregnancy. (bellaonline.com)
  • Let's start with a quick recap of the menstrual cycle phases. (yoppie.com)
  • Everything you need to know about the Menstrual Cycle Phases. (pinterest.ch)
  • It's also worth noting that the follicular phase naturally shortens as women near menopause and corresponds with the decline in fertility that women begin to experience in their late thirties. (purewow.com)
  • The Follicular Phase technically overlaps with the Menstrual Phase, starting with the first day of your period. (drdanielledesroche.com)
  • The follicular phase overlaps with the menstrual phase and begins on the first day of your period. (greatist.com)
  • A phase 1 trial had shown it to be safe, so Neelapu and colleagues combined it with rituximab (known commercially as Rituxan), another monoclonal antibody that hits CD20, a surface protein on immune system B cells. (sciencedaily.com)
  • So, what exactly is the follicular phase and what's going on with our hormones during it? (myoovi.us)
  • With each phase, I'll cover how to sync your life with your cycle to have healthier hormones and easier periods! (drdanielledesroche.com)
  • However, fish oil during the Follicular Phase can help your body make hormones, if you are low. (drdanielledesroche.com)
  • Described throughout this series are the four phases of the menstrual cycle, the hormones involved in each phase, the related energetics of the Moon and Earth cycles and the corresponding elemental wisdom. (thenectarnest.ca)
  • Our bodies are in a constant cycle of changing hormones and internal phases that affect our mind and body. (heraldextra.com)
  • During this phase, the pituitary gland releases luteinizing hormones, starting out in low levels and continuously rising as more is released. (mindbodygreen.com)
  • They also contain lignans and essential fatty acids that support the hormones present during the luteal phase. (mindbodygreen.com)
  • Blood and tissue from the uterine lining is also shedding during this phase, so your body and your hormones are undergoing drastic fluctuations-be gentle on yourself. (mindbodygreen.com)
  • Nurturing your mind and body during this time will not only help you optimise this phase but will also lay the foundation for a healthy ovulation and smoother luteal phase (aka reduced PMS symptoms! (myoovi.us)
  • The increase of estrogen and energy during this phase following the hormonal flatline of the menstrual phase may create some feelings of unsteadiness, angst and overactivity in the mind as well as physical symptoms may be experienced in the form of headaches, anxiety, constipation and/or breast tenderness which can all be effectively addressed through bodywork. (thenectarnest.ca)
  • While you may still experience some PMS symptoms in this phase too, the more likely symptoms of the follicular phase tend to include increased energy levels, more focus, and a slight increase in body temperature. (yoppie.com)
  • This may simply be in contrast to the more negative PMS symptoms we tend to experience in other phases of the cycle, but there's no denying that for some this is the happiest time in their month. (yoppie.com)
  • Periods on Instagram: 'SUPPORT YOUR CYCLE 🌙 🌹Menstrual Phase: these are the days when you are ON your period (should be about 3-7 days) Replenish nutrients lost in the blood, manage or prevent symptoms, and nourish your body. (pinterest.ch)
  • This article delves into the multifaceted world of the period cycle, exploring its phases, symptoms, and health implications. (healthifyme.com)
  • LH induces androgen synthesis by thecal cells, stimulates proliferation, differentiation, and secretion of follicular thecal cells and increases LH receptor expression on granulosa cells. (wikipedia.org)
  • [ 1 ] approximately 20% are likely to be follicular lymphomas. (medscape.com)
  • [ 2 ] No sex preponderance is seen for follicular lymphomas, but the incidence increases with age and varies across racial groups. (medscape.com)
  • Despite the fact that most follicular lymphomas are advanced at the time of diagnosis, many patients may not require treatment for prolonged periods of time, and the median survival of patients with follicular lymphomas has historically been approximately 8-10 years. (medscape.com)
  • Follicular waves are best described as the phase when follicles have matured sufficiently and rupture, leading to ovulation. (wikipedia.org)
  • When it's time to start the cycle over again, the follicular phase comes in, which is when the little pods containing eggs (AKA follicles) get busy prepping an egg to send down the fallopian tubes when the time is right. (yoppie.com)
  • The follicular phase is characterised by the growth and maturation of ovarian follicles, which house the developing eggs. (healthifyme.com)
  • Inhibin B will eventually blunt the secretion of FSH toward the end of the follicular phase. (wikipedia.org)
  • FSH secretion begins to rise in the last few days of the previous menstrual cycle, and is the highest and most important during the first week of the follicular phase (Figure 1). (wikipedia.org)
  • During the late follicular phase, estrogen has a positive influence on LH secretion, instead of suppressing pituitary LH secretion as it does early in the follicular phase. (medscape.com)
  • The follicular phase corresponds to the Waxing Moon and the season of Spring, the beginning of a new cycle of growth. (thenectarnest.ca)
  • Increased sleep disruption was found in the late luteal phase, which corresponds with the days directly prior to menses. (eurekalert.org)
  • METHODS: Women aged 30-44 years with no history of infertility who had been trying to conceive for less than 3 months provided early-follicular phase serum and urine (N=100). (cdc.gov)
  • To test responses of females with regular cycles during midfollicular and midluteal phase and of users of monophasic oral contraception pills (OCPs) to visual food cues. (medscape.com)
  • In females with regular cycles, brain regions associated with homeostasis but also the reward system, executive frontal areas, and afferent visual areas were activated to a greater degree during the luteal compared with the follicular phase. (medscape.com)
  • This phase 2 trial (NCT01190449) evaluated ofatumumab in patients with untreated, low/intermediate-risk FL International Prognostic Index (FLIPI), advanced-stage FL to determine single-agent efficacy. (johnshopkins.edu)
  • As reported in the Journal of Clinical Oncology by Teachey et al, the phase III Children's Oncology Group AALL1231 trial has shown that the addition of bortezomib to a modified augmented Berlin-Frankfurt-Münster (BFM) backbone improved survival outcomes in patients with newly diagnosed T-cell. (ascopost.com)
  • Abnormal uterine findings were de Recherche et d'Application en identified in 95.8% of patients attending hysteroscopy at GESHRTH. (who.int)
  • The period phase marks the beginning of the period cycle and is characterised by the shedding of the uterine lining that was built up during the previous cycle in preparation for pregnancy. (healthifyme.com)
  • Each phase has a distinct hormonal secretory milieu. (medscape.com)
  • Period phases are characterised by distinct physiological changes and hormonal fluctuations that work together to prepare the body for potential pregnancy and maintain overall reproductive health. (healthifyme.com)
  • [ 7 ] To unravel mechanistic insights into the differential eating patterns during the menstrual cycle, we tested hormonal levels and functional magnetic resonance imaging (fMRI) brain responses to visual food cues of lean females with a regular cycle during midfollicular and midluteal phases. (medscape.com)
  • The duration of the follicular phase can differ depending on the length of the menstrual cycle, while the luteal phase is usually stable, does not really change and lasts 14 days. (wikipedia.org)
  • Luteal phase lasts approximately 9 days before brown spotting begins, which goes on for 3-5 days until actual bleeding begins. (180degreehealth.com)
  • This phase lasts from the time the bleeding starts until the bleeding stops. (heraldextra.com)
  • This phase typically lasts from 11 to 27 days, or an average of about 16 days . (greatist.com)
  • Length of phase: lasts 3-7 days. (weightandwellness.com)
  • Length of phase: lasts from 10-22 days. (weightandwellness.com)
  • Length of phase: lasts about 9-16 days. (weightandwellness.com)
  • GnRH interacts with the anterior pituitary gland to stimulate release of FSH in the follicular phase. (medscape.com)
  • A 2018 study found that in the late luteal phase, females are sadder and experience less amusement in comparison with males. (medicalnewstoday.com)
  • Menstrual phase affected sleep efficiency, wake after sleep onset (WASO), number of awakenings per night, and sleep fragmentation index, in keeping with increased sleep disruption in the late luteal phase. (eurekalert.org)
  • Compared with the early follicular phase, sleep efficiency decreased by 3.3 percent, WASO increased by 15 minutes, and number of awakenings per night increased by three in the late luteal phase. (eurekalert.org)
  • Short-term caloric restriction had negative effects on sleep in both the late follicular phase, just before ovulation, and in the late luteal phase, just before the onset of menses," said Kim, who performed this study at the National Institute of Environmental Health Sciences (NIEHS). (eurekalert.org)
  • Decreased energy availability increased sleep disruption, with less sleep efficiency, greater WASO, and higher sleep fragmentation index in the late follicular phase in addition to the effects noted above in the late luteal phase. (eurekalert.org)
  • After ovulation, the luteal phase begins. (medicalnewstoday.com)
  • When the luteal phase begins, your body is preparing for a potential pregnancy that would have started during ovulation. (heraldextra.com)
  • This follicular wave involves multiple surges in the levels of FSH to initiate follicular development. (wikipedia.org)
  • According to Dr. Premru-Sršen (M.D., Ph.D), staff OB GYN for Bellabeat Ivy , the follicular phase "is a great time within your body's natural cycle…a week where you'll feel energized, positive, productive and vibrant, thanks to the increase in estrogen and testosterone levels. (purewow.com)
  • Your luteal phase actually ends when you start the true bleeding, not the spotting, so your luteal phase is longer than 9 days, but spotting before your period generally does indicate low progesterone levels. (180degreehealth.com)
  • With increased energy levels, your Spring phase is a great time to get active and try new things! (myoovi.us)
  • This is nothing to worry about, but some causes include using birth control pills for an extended period of time, and low levels of vitamin D. If you're trying to get pregnant, don't worry - you're just as likely to conceive as those with a 'normal' length follicular phase. (yoppie.com)
  • The effect of elevated peripheral progesterone levels in the late follicular phase seems to be on the endometrium and the window of implantation, which may lead to asynchrony between the endometrium and the developing embryo. (artfertilityclinics.com)
  • Follicular Phase: the day after you period ends up until ovulation Support estrogen metabolism, healthy egg quality, and rising energy levels. (pinterest.ch)
  • Estrogen and progesterone levels are at their lowest during this phase. (healthifyme.com)
  • During this phase, rising levels of estrogen prepare the body for ovulation, setting the stage for potential fertilization. (healthifyme.com)
  • Chances are you'll feel pretty swell (relatively speaking) during the follicular phase no matter what. (purewow.com)
  • As the late follicular phase occurs just before ovulation, this suggests that females value kissing to assess a potential mate, when the chances of conception are at their highest. (medicalnewstoday.com)
  • On the flip side, a shorter follicular phase can affect your chances of getting pregnant and could be a super early sign of menopause. (yoppie.com)
  • Diagnosis and appropriate correction of intrauterine anomalies are considered et d'Application en Chirurgie essential in order to increase chances of conception. (who.int)
  • Le diagnostic et la prise en charge adéquate des lésions intra cavitaires permettent d'am liorer les chances de conception. (who.int)
  • What if my follicular phase is shorter than it should be? (yoppie.com)
  • Females tend to feel more sexual arousal toward the end of the follicular phase when there is a surge of the luteinizing hormone (LH). (medicalnewstoday.com)
  • Oestrogen is kind of like the Beyoncé of the hormone world - which is why many people find that they feel their best during their follicular phase! (myoovi.us)
  • The hypothalamus is the initiator of the follicular phase via gonadotropin-releasing hormone (GnRH). (medscape.com)
  • Ovulation is important for our health during the reproductive years because it sets off the next phase of hormone production, which we need to feel our best. (weightandwellness.com)
  • CONCLUSION: Early-follicular phase antimullerian hormone appears to be associated with natural fertility in the general population. (cdc.gov)
  • It is a brief yet crucial phase that provides a window of fertility for potential conception. (healthifyme.com)
  • Eating pumpkin seeds and flax seeds support estrogen production 1 (which is rising during the follicular phase) and help estrogen and testosterone peak appropriately. (mindbodygreen.com)
  • and an eruptive phase (verruga peruana) characterized by red-to-purple nodular skin lesions. (cdc.gov)
  • Fortunately, there are things you can do and signs to be aware of that can help your body take advantage of each of those phases. (heraldextra.com)
  • One of the signs that you are in your follicular phase is an increased body temperature and a higher sex drive. (heraldextra.com)
  • Remember estrogen is rising during this phase, which is good for the endometrial lining. (drdanielledesroche.com)
  • Long story short: The follicular phase is when your body does its baby-making prep work. (purewow.com)
  • As such, the OB GYN typically encourages women to "[socialize], schedule important meetings, learn new skills and move their body more rigorously" during the follicular phase-namely because this is the time of the month when you're most likely to be on your A game. (purewow.com)
  • Here we'll break down exactly what's happening in your body during this time, how it might impact your physical and mental health and the things you can do to make the most of this phase of your cycle! (myoovi.us)
  • Please keep in mind that each body is unique and not all cycle phases will align with the specific Moon and Earth phases that are listed ~ and that is completely okay, whenever you bleed is perfect! (thenectarnest.ca)
  • Instead, be able to recognize your body's signals and determine what phase you are in based on what your body is telling you. (heraldextra.com)
  • Take advantage of this phase by engaging in more cardio and filling your body with greens such as salads, fruits and vegetables. (heraldextra.com)
  • What happens in your body during your luteal, ovulation & follicular phases. (pinterest.ch)
  • So doing high intensity workouts during this phase can counterbalance to a slower metabolism. (carrotsncake.com)
  • But Dr. Premru-Sršen says that you can get an even bigger boost if you pay close attention to your diet at this time, and recommends eating "leafy greens, sweet potatoes and foods high in vitamin E for maximum impact and energy during this menstrual cycle phase. (purewow.com)
  • This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (globaldata.com)
  • What is Phase Transition Success Rate (PTSR)? (globaldata.com)
  • GlobalData's Drug-Specific Likelihood of Approval (LoA) calculates the Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA) customized to individual drug. (globaldata.com)
  • A study has found that 68% of women tended to display two follicular wave developments before ovulation while the remaining had three waves. (wikipedia.org)
  • How do women typically feel during the follicular phase? (purewow.com)
  • In nine hyperthyroid women studied in the follicular phase of the menstrual cycle basal plasma LH concentrations and LH and FSH responses to GnRH were increased compared to those in nine normal women. (lu.se)
  • The women also completed five-day diets during the early follicular phases of each cycle. (eurekalert.org)
  • I started researching and became personally invested in helping women figure out this tricky phase of life that is stealing a lot of joy. (weightandwellness.com)
  • In other words, the follicular phase always starts when Aunt Flow shows up, but its duration is typically between 10 to 17 days, and can even be as long as 27 days, depending on when ovulation occurs. (purewow.com)
  • But be careful… Studies have shown that muscle and tendon injuries occur almost twice as often in the late follicular phase (around day 7 to day 15) compared to the early follicular or luteal phase, probably because oestrogen can make our tendons more lax. (myoovi.us)
  • Most pregnancies occurred after deviations from FDA directions, which include placement in the early follicular phase of the menstrual cycle, imaging at 3 months to document proper placement, and use of effective alternative contraception until documented occlusion (Level of evidence: II-3, fair, direct). (cdc.gov)
  • The next phase of your cycle is called the luteal phase: It follows ovulation and precedes your next period. (mindbodygreen.com)
  • Well, friends, it starts on the first day of your period , ends when you ovulate and happens to be the longest phase of a lady's monthly cycle. (purewow.com)
  • The menstrual cycle begins on day 1 of a period and consists of two main phases: the follicular phase and the luteal phase. (medicalnewstoday.com)
  • Known as our 'Inner Spring' our Follicular Phase technically starts on Day 1 of our period - but most people don't get those lovely follicular feels until their period starts to end. (myoovi.us)
  • Perhaps the most infamous phase of the menstrual cycle is the period. (heraldextra.com)
  • If a pregnancy doesn't occur, the lining of the uterus sheds and this is the menstrual phase, also known as your period. (yoppie.com)
  • Even if you still get your period as normal, if you track your cycle you may notice your follicular phase shortening from your late 30s onwards. (yoppie.com)
  • From the initial period phase to the peaks of ovulation and the subsequent luteal phase, each stage contributes to the delicate orchestration of the cycle. (healthifyme.com)
  • The period cycle is a complex and dynamic process that occurs in individuals with reproductive systems, marking the reproductive phase of their lives. (healthifyme.com)
  • This phase starts onday 1 of your period until ovulation. (weightandwellness.com)

No images available that match "follicular phase"